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MY PARENTS, NIGHAT & ALISON
ABSTRACT
The ability of enzymes to withstand extreme temperatures and remain 
active is of great commercial interest. In seeking to understand the structural 
basis of enzyme thermostability many studies have compared and contrasted 
enzymes from mesophilic and thermophilic hosts. Russell et al. (1997) have 
made predictions of structural features responsible for the enhanced 
thermostability of citrate synthase (CS) from the archaeon Pyrococcus furiosus 
(Pf), optimum growth temperature 100°C, based on structural comparisons of 
citrate synthases from pig, Thermoplasma acidophilum (Tp), optimum growth 
temperature 55°C, and P.furiosus. . Some of the key findings from this 
comparison are that the structure of P/CS relative to pig and TpCS is more 
compact, has better complementarity between the subunits of the dimer, has 
fewer thermolabile residues, a greater number of intersubunit ionic interactions 
and an additional subunit interface interaction at its C-terminii.
Site-directed mutants have been made of P/CS to test the importance of 
the additional C-terminal subunit interaction, and of the 5 membered subunit 
interface ionic network, to thermostability. Denaturation studies of these 
mutants have confirmed that these structural features do play a role in the 
thermostability of P/CS.
The crystal structures determined for TpCS and P/CS show that each 
monomer of the enzyme consists of a large and a small domain. Chimaeric 
citrate synthases have been constructed, where the small domains have been 
swapped between P/CS and TpCS, to determine where the principal 
determinants of thermostability and catalytic activity lie. This study has shown 
that the key determinants of thermostability are located in the large domain of 













1.2 Citrate synthase....................................................................................................... 1
1.2.1 Citrate synthase as the model protein............................................................. 1
1.2.2 CS mechanism...................................................................................................3





1.4.1 What is thermostability ? .................................................................................11
1.4.2 Strategies for investigating thermostability....................................................13
1.4.3 Determinants of thermostability...................................................................... 14
1.4.3.1 Intrinsic determinants of thermostability.....................................................15
1.4.3.1 a Ionic interactions....................................................................................... 15
1.4.3.1 b Hydrophobic effect.................................................................................... 16
1.4.3.1c Hydrogen bonds......................................................................................... 17
1.4.3.1d Disulphide bonds........................................................................................ 17
1.4.3.1e Helix stabilising factors...............................................................................18
1.4.3.1f Reduction in the entropy of unfolding....................................................... 19
1.4.3.1g Resistance to covalent destruction........................................................... 20
1.4.3.1h Stabilisation of loops/reduction in flexibility.............................................20
1.4.3.2 Extrinsic determinants of thermostability....................................................21
1.5 Citrate synthase: a case study;............................................................................ 22
IV
1.6 Other detailed comparisons...................................................................................31
1.7 Are there general rules for protein thermostability ?...........................................32
1.8 Aims and objectives...............................................................................................34
CHAPTER 2
Materials and Methods
2.1. Reagents, enzymes and other materials...........................................................35
2.2 Molecular biology methods.................................................................................... 37
2.2.1 Small scale preparation of plasmid DNA -’Miniprep’.................................... 37
2.2.2 Large scale preparation of plasmid DNA -’Maxiprep’ .................................. 38
2.2.3 Precipitation of DNA........................................................................................ 39
2.2.4 Determining the concentration and purity of DNA........................................39
2.2.5 Restriction digestion of DNA.......................................................................... 40
2.2.6 5' Phosphorylation of oligonucleotides.........................................................40
2.2.7 DNA ligation..................................................................................................... 40
2.2.8 Transformation of competent cells................................................................. 41
2.2.9 Agarose gel electrophoresis........................................................................... 41
2.2.10 DNA purification from agarose gels............................................................. 42
2.2.11 Polymerase chain reaction (PCR)............................................................... 42
2.2.12 DNA sequencing........................................................................................... 43
2.2.13 Software..........................................................................................................44
2.3 Biochemical techniques......................................................................................... 44
2.3.1 Determination of protein concentration.........................................................44
2.3.2 Protein expression.......................................................................................... 45
2.3.3 Preparation of cell extracts..............................................................................45
2.3.4 Protein purification.......................................................................................... 45
2.3.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE).................................................................................................... 46
2.3.6 Spectrophotometric assay for citrate synthase............................................. 47




Creation of citrate synthase domain swap mutants
3.1 Introduction..............................................................................................................49
3.2 Methods................................................................................................................... 52
3.2.1 Site directed mutagenesis...............................................................................52
3.2.2 Transfer of proteins for N-terminal sequencing............................................54
3.3 Results.................................................................................................................... 55
3.3.1 Design of chimaeric domain swap mutants...................................................55
3.4 Site directed mutagenesis..................................................................................56
3.4.1 Cloning of the P.furiosus CS gene into pALTER-1.......................................56
3.4.2 Cloning of the T.acidophilum CS gene into pALTER-1............................... 58
3.4.3 Mutagenesis reactions.................................................................................... 59
3.4.4 Exchange of the regions coding for the small domains within pALTER-
1 ............................................................................................................................. 60
3.4.5 Sequencing of pBAP 3006 and pBAP 3106 CS mutants............................64
3.5 Expression of domain swapped mutants............................................................. 66
3.5.1 Cloning of PYR::tp chimaeric citrate synthase into pRec7-Nde1................66
3.5.2 Cloning of the wildtype P/CS into the pRec7-Nde1 vector.......................... 69
3.5.3 DNA sequencing of pBap 3110, and pBap 3031 .........................................69
3.5.4 Cloning of TP::pyr CS into pUC19..................................................................70
3.5.5 Cloning of the TP::pyr CS into the pRec7-Nde vector................................. 71
3.5.6 DNA sequencing of TP::pyr in pUC19 (pBAP3007) and in pRec7-Nde1 
(pBAP3008)................................................................................................................ 73
3.5.7 N-terminal sequencing of PYR::th CS (pBAP3110) and TH::pyr CS 
(pBAP3007) mutant proteins........................................................................... 74
3.6 Purification of CS enzymes...................................................................................75
3.7 Characterisation of the purified CS enzymes......................................................80
3.7.1 Determination of the kinetic parameters of the CS’s ................................... 80
3.7.2 Thermal stability of the four CS’s ...................................................................85
3.8 Discussion............................................................................................................... 89
3.8.1 Use of pAlter-1 kit in site directed mutagenesis..........................................89
3.8.2. Kinetic studies of the mutants....................................................................... 89
3.8.3 Thermal inactivation of mutant citrate synthases.........................................91
3.8.4 Concluding comments..................................................................................... 92
VI
CHAPTER 4
Production of P/CS C-terminal mutants
4.1 Introduction..............................................................................................................94
4.2 Creation of the Pf-2 C-terminal deleted P/CS mutant.........................................98
4.3 Creation of the Pf-13 C-terminal deleted P/CS mutant.....................................100
4.5 Purification of the two P/CS C-terminal mutants............................................... 102
4.6 Characterisation of the C-terminally deleted mutants....................................... 106
4.6.1 Determination of the kinetic parameters......................................................106
4.6.2 Thermal stability of the C-terminally deleted mutated CS’s ...................... 110
4.7 Discussion............................................................................................................. 113
4.7.1 Kinetic Studies of the mutants...................................................................... 113
4.7.2 Thermal inactivation of the C-terminal mutants.......................................... 114
4.7.3 Concluding Comments.................................................................................. 116
CHAPTER 5




5.3 Production of the Alanine and Serine P/CS subunit interface mutants 125
5.3.1 Production of the first PCR product..............................................................125
5.3.2 Production of the second PCR product....................................................... 127
5.3.3 Cloning of the PCR 2 products into pBAP3031.......................................... 128
5.3.4 Sequencing of subunit interface mutants pBAP3040 and 3041...............130
5.3.5 Remaking the two subunit interface mutants............................................. 132
5.3.5.1 Remaking the serine subunit interface mutant........................................133
5.3.5.2 Remaking the alanine subunit interface mutant......................................134
5.4 Production and purification of the 2 subunit interface P/CS mutants.............136
5.5 Characterisation of the subunit interface P/CS mutants...................................140
5.5.1 Determination of the kinetic parameters......................................................140
5.5.2 Thermal stability of the subunit interface CS’s ........................................... 144
5.6 Discussion............................................................................................................. 147
VII
5.6.1 Kinetic Studies of the mutants...................................................................... 147
5.6.2 Thermal inactivation of the subunit interface mutants............................... 147









Figure 1.1 Position of citrate synthase within the citric acid cycle.............................2
Figure 1.2 The Remington model for the catalytic mechanism of pig C S ............... 5
Figure 1.3 Crystal structure Of P/CS........................................................................... 7
Figure 1.4 Structure of P/CS viewed down the 2-fold axis of the dimer...................8
Figure 1.5 Ribbon diagrams of an orthogonal view of pig, Tp, and P/CS 24
Figure 1.6 Schematic representation of the loop region of pig, Tp and P/CS 27
Figure 1.7 Ionic interactions present in pig, Tp, and P/CS...................................... 28
Figure 1.8 Isoleucine residues present in pig, DS23r, and P/CS........................... 30
Figure 3.1 The altered sites®ll in vitro mutagenesis procedure............................. 53
Figure 3.2 The DNA sequence adjacent to the Apa1 and BspE1 sites in 
Pf and TpCS, and the base changes necessary to create an
Apa1 site in TpCS and a BspE1 site in P/CS.........................................55
Figure 3.3 Amino acid alignment between Pf, and TpCS..................57
Figure 3.4 Primers designed to introduce an Apa1 site into TpCS, and a
BspE1 site into P/CS............................................................................. 59
Figure 3.5 Restriction digestion of pBAP3005 and pBAP3105 clones with
Apa1, BspE1, and Hindlll restriction enzymes.....................................  61
Figure 3.6 Digestion of TpCS, and P/CS with Apa1 and BspE1, to cut
out the regions coding for the small domains..................................... 62
Figure 3.7 Diagram showing the position of the Hindlll sites in the CS’s............ 63
Figure 3.8 Hindlll digestion of 4CS’s within the pAlter-1 vector........................... 63
Figure 3.9 Positions at which sequencing primers bind on
clones pBAP3006 and pBAP3106........................................................65
Figure 3.10 Oligonucleotides designed to add a Nde1 and Kpn1 site to
Pyr::tp C S ................................................................................................66
Figure 3.11 PCR products from the amplification of pBAP3106 to add Nde1
and Kpn1 sites to PYR::tp CS............................................................... 67
Figure 3.12 Nde1, Kpn1 digest of pBAP3110 construct......................................... 69
Figure 3.13 EcoR1, Sph1 digest of pBAP3007 construct....................................... 71
Figure 3.14 Oligonucleotides designed to add a Nde1 and Kpn1 site to
TP::pyr C S ............................................................................................. 72
Figure 3.15 Nde1 digest of TP::pyr CS in pRec7-Nde1 recombinants.................. 73
Figure 3.16 SDS-PAGE analysis of fractions from the purification of TpCS,
and TP::pyr C S .......................................................................................77
IX
Figure 3.17 SDS-PAGE analysis of fractions from the purification of P/CS
and PYR::tpCS.......................................................................................78
Figure 3.18a V against S plot of the data used to determine the Km and Vmax
values for PYR::tp CS for the substrate oxaloacetate.......................83
Figure 3.18b V against S plot of the data used to determine the Km and Vmax
values for PYR::tp CS for the substrate Ac-CoA.................................83
Figure 3.18c V against S plot of the data used to determine the Km and Vmax
values for TP::pyr CS for the substrate oxaloacetate........................ 84
Figure 3.18d V against S plot of the data used to determine the Km and Vmax
values for TP::pyr CS for the substrate acetyl-CoA............................84
Figure 3.19 Relative thermostability of P/CS, TpCS, and the domain swap
mutants at 85°C......................................................................................87
Figure 3.20 Relative thermostability of PYR::tp CS to P/CS at 95°C................. 88
Figure 4.1 Space filling representation of the P/CS dimer, showing the
C-terminal residues of each monomer wrapping around
the other monomer................................................................................ 95
Figure 4.2 Amino acid alignment of CS C-terminal regions from Archaea, a
Eukaryote, gram negative and gram positive bacteria....................... 97
Figure 4.3 MAA-15 Primer........................................................................................ 98
Figure 4.4 PCR products and Nde1 and Kpn1 digest of pRec7-Nde1 vector... 99
Figure 4.5 MAA-16 Primer...................................................................................... 100
Figure 4.6 Nde1 digest of vector + insert recombinants from the cloning of
the -13 P/CS PCR product into pRec7-Nde1 vector....................... 102
Figure 4.7 SDS-PAGE analysis of fractions from the purification of the Pf-2,
and the Pf-13 mutants......................................................................... 105
Figure 4.8a V against S plot of data used to determine the Km and Vmax
values for the Pf-2 mutant for the substrate oxaloacetate............... 108
Figure 4.8b V against S plot for the substrate acetyl-CoA of data used to
calculate the Km and Vmax values of the Pf-2 mutant........................ 108
Figure 4.8c V against S plot of data used to determine the Km and Vmax
values for the Pf-13 mutant for the substrate oxaloacetate 109
Figure 4.8d V against S plot of data used to calculate the Km and Vmax
values of the Pf-13 mutant for the substrate Ac-CoA...................... 109
Figure 4.9 Relative thermostability of P/CS and the C terminally deleted
mutants at 103°C..................................................................................112
X
Figure5.1 Five membered intersubunit ion pair networks in P/CS,
viewed down the two fold axis of the dimer........................................118
Figure 5.2 Representation of the 5 membered ionic network at the
subunit interface of P/CS...................................................................... 119
Figure 5.3 Ion pairs present at the 8 a-helical sandwich subunit interface
region of CS (calculated at a cut-off distance of 4A) for pig, DS23R,
S.solfataricus, T.acidophilum, and P.furiosus..................................... 120
Figure 5.4 Steps in the nested PCR procedure....................................................124
Figure 5.5 Primers used to create the PCR 1 products........................................125
Figure 5.6 PCR 1 products..................................................................................... 126
Figure 5.7 Products of PCR 2 reaction..................................................................128
Figure 5.8 Restriction digest of potential subunit interface mutants.................. 130
Figure 5.9 DNA base sequence of the subunit interface mutants
spanning the deleted region................................................................ 131
Figure 5.10 Restriction sites used to subclone subunit interface mutants into
P/CS in pRec7-Nde1 (pBAP3031).....................................................  132
Figure 5.11 Restriction digest of pBAP3040, and pBAP3031 with Nde1
and BstX1................................................................................................133
Figure 5.12 BamH1 digest of potential serine subunit interface mutants 134
Figure 5.13 Restriction digestion of pBAP3041, and pBAP3031 with Nde1,
and Bsa1.................................................................................................136
Figure 5.14 SDS-PAGE analysis of fractions from the purification of the
asp113/ser and asp113/ala mutants....................................................139
Figure 5.15a V against S plot for the asp113/ala mutant for the substrate
oxaloacetate.......................................................................................... 142
Figure 5.15b V against S plot of data used to determine the Km and Vmax
values for the asp 113/ala mutant for the substrate Ac-CoA 142
Figure 5.15c V against S plot for the asp113/ser mutant for the substrate
oxaloacetate......................................................................................... 143
Figure 5.15d V against S plot of data used to determine the Km and Vmax
values for the asp113/ser mutant for the substrate Ac-CoA 143
Figure 5.16 Relative thermostability of the subunit interface mutants to
P/CS at 103°C....................................................................................... 146
XI
TABLES
Table 1.1 The number of ion pairs in pig, Tp, and P/CS, using a 6, 5,
and 4 A cut off distance between charged groups............................ 26
Table 3.1 Purification of wildtype Tp and P/CS and domain swap mutants 79
Table 3.2 Comparison of turnover numbers, Km values for the
substrates oxaloacetate, Ac-CoA, and the specific activities
of the four CS’s, at 55°C..........................................................     81
Table 3.3 Inactivation rate constants for the chimaeric and wildtype CS’s
at 85°C and 95°C...................................................................................86
Table 4.1 Purification of Pf-2 and Pf-13 P/CS mutants......................................104
Table 4.2 Km and Vmax values for P/CS and the C-terminal deleted
P/CS mutants....................................................................................... 106
Table 4.3 Rate constants for denaturation of P/CS, and the C-terminal
mutants, and times at which 50% of the enzyme's activity
remains, at 103°C................................................................................111
Table 5.1 Purification of the asp113/ser and asp113/ala subunit
interface mutants..................................................................................138
Table 5.2 Km and specific activity values determined for P/CS, and
the subunit interface mutants at 55°C ............................................... 141
Table 5.3 Rate constants for denaturation of the subunit interface
mutants and P/CS, and times at which 50% of the enzyme's 
activity remains at 103°C......................................................................145
ACKNOWLEDGEMENTS
I would like to thank my supervisors Professor Mike Danson and Dr 
David Hough for allowing me the opportunity to do this PhD, and for the time 
that they have spent with me in a range of useful discussions. Thanks are also 
due for their guidance throughout the project, and help in the production of this 
manuscript.
I would also like to thank all of my friends at the Centre For Extremophile 
research, both past and present, for being such good fun, making it a pleasure 
to come to work. Special thanks to Dr Carl Thompson, Dr Rupert Russell, and 
Dr Cameron Dunn for their help with my many computing ‘problems’.
I gratefully acknowledge the BBSRC who provided the sponsorship for 
this project.
Finally a big thank you to my wife Nighat for her patience, 
encouragement and understanding throughout this project. I would also like to 














































SDM Site directed mutagenesis
SDS Sodium dodecyl sulphate
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis
TAE 40mMTris-acetate, 1mM EDTA
TEMED T etramethylethylenediamine
TLN Thermolysin








The work presented in this thesis aims to contribute to our understanding 
of the intrinsic factors that contribute to the structural basis of protein 
thermostability. Citrate synthase from the Archaea has been chosen as the 
model protein in this study. This introduction will therefore give a description of 
citrate synthase, the Archaea, and intrinsic features that are thought to be 
important in protein stability.
1.2 Citrate Synthase
This section gives a general background on CS, explaining why we have 
chosen it as our model enzyme, describing its mechanism of action, and the 
relationship between its structure and the taxonomic status of the organism from 
which it was isolated.
1.2.1 Citrate synthase as the model protein
CS was chosen by our group to investigate the structural determinants of 
thermostability for the following reasons:
1. Citrate synthase plays an important role in cell metabolism, in that it is the first 
enzyme of the citric acid cycle (Krebs & Lowenstein, 1960). The citric acid 


































NADH + C 02
Figure 1.1 Position of citrate synthase within the citric acid cycle.
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metabolism is reflected in the fact that the enzyme is conserved throughout the 
three domains of life, and has maintained the same function throughout evolution 
(Danson, 1988; Muiretal., 1994).
2) There is a wide range of sequence information on CS, with around 50 
sequences listed in the database. Crystal structures have been determined for 
the open (ligand free) and closed (substrate bound) forms of the enzyme from pig 
and chicken heart (Remington, 1992; Remington et al., 1982; Weigand et al., 
1984), the open form from the thermophilic archaeon Thermoplasma acidophilum 
(Russell et al., 1994), the closed form of the hyperthermophilic archaeon 
Pyrococcus furiosus (Russell et al., 1997), and the psychrophilic bacterium 
DS23r (Russell et al., 1998). Our group has studied CS for a number of years, 
cloning, sequencing, expressing, and crystallising CS’s from organisms that 
inhabit environments which range from the Antarctic (DS23r) to geothermally 
heated marine sediments (P. furiosus).
3) The enzyme can be easily purified (James et al., 1994), and there is a good 
assay of its activity (Srere et al., 1963).
1.2.2 CS Mechanism
Citrate synthase catalyses the condensation of acetyl-CoA and 
oxaloacetate to form citrate and free CoA, and thereby effects the entry of carbon 
into the citric acid cycle.
The catalytic mechanism has been studied extensively in pig heart CS. 
The current working hypothesis for the mechanism of the CS catalysed reaction 
in pig, is that oxaloacetate binds first to the enzyme’s active site, causing a large 
conformational change from the enzyme’s open form to a closed form. His320
3
causes polarisation of the oxaloacetate carbonyl bond thereby increasing the 
positive charge on the 2-carbon of oxaloacetate, making it more susceptible to 
condensation with Ac-CoA. Binding of Ac-CoA to the CS-OAA complex is 
followed by a concerted acid -base reaction, where Asp375 is the general base 
and His 274 is the general acid. This causes an enolization of Ac-CoA (the 
methyl group being deprotonated) to yield an enolized intermediate, the proposed 
nucleophile that may be neutral or partially negatively charged. Additional 
conformational changes are believed to accompany this step. The nucleophile 
then condenses with the OAA to give citryl CoA. Citryl CoA is hydrolysed, 
possibly utilising Asp375, to yield citrate and free CoA. Finally a conformational 
change occurs to an open form to release the products. The proposed 
mechanism for CS is shown in Fig 1.2 (reproduced from McCormack, 1995). This 
scheme has been derived primarily from detailed kinetic analysis of wiidtype, 
chemically modified, and site directed mutants of CS’s (Bayer et al., 1981, Kurz 
et al., 1992, Evans et al., 1988, 1989, 1996; Alter et al., 1990, and references 
therein^pnd from analysis of CS crystal structures (Remington et al., 1982; 
Karpusas etal., 1990; Liao etal., 1991; Remington, 1992; Usher etal., 1994),
1.2.3 Relationship between enzyme structure and taxonomic status of 
organism
Studies of CS’s from the eukaryal and bacterial domains have shown a 
correlation between the taxonomic status of the organism and the subunit 
composition, catalytic activity, and regulatory properties of the enzyme 
(Weitzman and Danson, 1976; Weitzman, 1981; Danson, 1988). The enzyme 
from Eukarya, Archaea, and Gram-positive bacteria is an isosterically regulated 
homodimer (inhibited by ATP) whereas the majority of Gram-negative bacteria 
possess an allosterically regulated hexamer (inhibited by NADH and showing no 
response to ATP). The exceptions to this rule are the dimeric CS’s from the
4












Citryl CoA \ / Citryl CoA
COO" COO"SCoA SCoA






















Figure 1.2 The Remington model for the catalytic mechanism of pig CS 
(Remington, 1992). There are three steps, enolization of Ac-CoA, 
condensation with oxaloacetate, hydrolysis to release citrate and 
coenzyme A. Two mechanisms have been proposed for the hydrolysis 
step, step A (Remington, 1992), and step B (Alter et al., 1990).
Gram-negative organisms Thermus aquaticus, Rickettsia prowazekii, and 
Coxiella burnetii, which are also isosterically regulated by ATP. Despite this 
oligomeric variation, the subunit Mr is between 42,000 and 50,000 in all cases.
Each monomer of CS consists of two domains, a large domain and a 
small domain. The large domain contains residues that make up the subunit 
interface, while the small domain is mainly concerned with the catalytic activity of 
the enzyme. In pig CS the small domain is known to rotate relative to the large 
domain upon binding of substrates (Remington et al., 1982). In CS’s from pig, Tp 
and Pf, the average main chain p-factor for the small domain is higher than that 
of the large domain (Russell et al., 1997) indicating an increased flexibility of the 
small domain with respect to the large domain. In P/CS each monomer is 
composed of 16 a-helices. Fig 1.3 shows the crystal structure of P/CS, showing 
the dimeric nature of the enzyme, and bound citrate and CoA. Fig 1.4 shows the 
large and small domains, and the subunit interface of P/CS. The main monomer- 
monomer association for all the dimeric CS’s is an 8 a-helical sandwich, 
comprising 4 anti-parallel pairs of helices (F, G, L, and M). The enzyme is only 
active as a dimer as residues from each subunit contribute to each active site.
1.3 The Archaea.
On the basis of a comparison of 16SrRNA sequences, Woese et al (1990) 
proposed that life could be divided into three primary phylogenetic domains, the 
Archaea, the Eukarya, and the Bacteria. The Archaea are a phylogenetically 
distinct group of microrganisms that from comparison of the 16SrRNA genes, 
have been subdivided into two further groups, the Crenarchaeota and 
Euryarchaeota. The kingdom Crenarchaeota generally consists of 
hyperthermophiles or thermoacidophiles (some genera are Pyrodictium and
6
Figure 1.3 Crystal structure of P/CS, one monomer is shown in red, the 
other in yellow. Bound citrate and CoA are shown in their binding sites in 
grey.
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Figure 1.4 Structure of P/CS viewed down the 2-fold axis of the dimer. 
Key. 1) Large domain coloured in red and mauve. 2) Small domains are 
coloured pink. X—X) Subunit interface.
8
Thermofilum), while the kingdom Euryarchaeota spans a broader ecological 
range and includes hyperthermophiles (eg Pyrococcus and Thermoplasma), 
methanogens (eg Methanosarcina), and halophiles (eg Haloferax and 
Halobacterium) (Brown & Doolittle, 1997).
The Archaea can also be grouped phenotypically according to the 
extreme environmental niche in which they live. The extremophilic phenotypes of 
the Archaea include thermophiles, hyperthermophiles, psychrophiles, halophiles, 
methanogens, acidophiles, alkaliphiles and barophiles, (Danson & Hough, 1998). 
However PCR amplification and analysis of DNA from soil samples has shown 
that the Archaea inhabit a much wider range of habitats than previously assumed 
(Bintrim et al., 1997; Service, 1997); this, coupled with the fact that there are 
many examples of bacterial extremophiles, means that the definition of an 
Archaeon should be a phylogenetic one, as opposed to a phenotypic one. 
However, in this introduction, the Archaea for convenience will be discussed in 
terms of their phenotypic groups and this will be limited to a brief description of 
the thermophiles.
The extremophilic nature of the Archaea has generated considerable 
interest in their physiological adaptations to such extreme environments. 
Biotechnology companies are aiming to exploit the enhanced stability properties 
of enzymes from these organisms (Cowan, 1996; Danson & Hough, 1998; Huber 
& Stetter, 1998; Johnson, 1998). The reason we have used enzymes isolated 
from the Archaea to study thermostability is that these proteins must contain 
adaptations/modifications, compared with enzymes isolated from mesophilic 
organisms, to withstand such extreme conditions.
9
1.3.1 Thermophiles
The archael thermophiles are a diverse group of organisms that are 
characterised by their high growth temperatures of between 50-110°C (Woese et 
al., 1990). This group can be subdivided into those that grow optimally at 55°C- 
80°C (thermophiles), and organisms that grow optimally at 80°C-110°C 
(hyperthermophiles). The most common thermophilic habitats are between 50- 
70°C, examples of these include solar heated soil, decaying vegetation, and self­
heating coal tips. Habitats where the temperatures are greater than 70°C are 
relatively rare, and tend to be geothermally active regions.
Details of the Archaea from which the CS’s used in this project were 
originally isolated are given below.
Pyrococcus furiosus, a hyperthermophile whose name translates as 
furious fireball’ (furious referring to the rapid doubling time and strong motility of 
the organism), was originally isolated from geothermally-heated marine 
sediments in Italy, and grows between 70-103°C with an optimum growth 
temperature of 100°C (Stetter & Fiala, G, 1986). The organisms are spherically 
shaped, 0.8-2.5|nm in width, and are anaerobic heterotrophs, growing on starch, 
maltose and peptone substrates.
Thermoplasma acidophilum, a thermophile whose name translates as 
heat and acid loving, was first isolated from burning coal refuse piles (Darland et 
al., 1970) but has since been isolated from naturally occurring hot springs and 
solfataric fields (Segerer et al., 1988). It is an aerobe, whose cells are motile and 
highly irregular in shape due to the lack of a cell wall. It grows at temperatures of 
between 45-63°C, with an optimum temperature for growth of 59°C, and an 
optimum pH of 1-2.
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1.4 Protein Thermostability
1.4.1 What is thermostability ?
When exposed to sufficiently elevated temperatures all enzymes will 
eventually lose catalytic activity. Thermally induced enzyme inactivation is 
classified as reversible or irreversible depending on whether activity is restored 
following a return to ambient conditions (Lumry & Eyring, 1954):
where N is a native catalytically active enzyme, U is a reversibly thermally 
unfolded enzyme, and I is an irreversibly thermoinactivated enzyme. The first 
step in this scheme is the reversible denaturation of an enzyme’s native 
conformation, and K defines the equilibrium constant between the N and U forms 
of the enzyme. The subsequent irreversible thermoinactivation processes, 
described by the rate constant k, can involve both conformational and covalent 
changes that are specific for individual enzymes. These changes are frequently 
accompanied by aggregation and precipitation.
When an enzyme is described as being thermostable what is implicit in 
this statement is that it is able to withstand thermally induced enzyme inactivation 
to a degree. There is a considerable interest in the molecular mechanisms that 
contribute to stability, because by understanding these, biologists hope to be able 
to engineer stability into enzymes, so that they can be used in industrial and 
medical applications that employ conditions quite different to those in which the 
enzyme has evolved to function in nature. In some cases, lessons from nature 
have been applied in the engineering of more stable variants of existing industrial 
enzymes (Rojkova et al.,1999; Nosoh & Sekiguchi, 1990). Also an understanding
of the structural basis of enzyme stability may explain how some organisms can 
tolerate extreme conditions of temperature and pH.
The conformational stability of a protein can be defined as the difference 
in the free energy between the folded and unfolded conformations under 
physiological conditions. For most naturally occurring globular proteins this is 
remarkably low, being estimated at between 5-15 kcal/mol (Pace, 1990). It may 
be advantageous for organisms to have proteins for which the folded active 
conformation is only marginally more stable than the unfolded inactive 
conformations. The reasons for this are not clear but may be related to the 
protein’s turnover or function (Fersht & Serrano, 1993; Arfin & Bradshaw, 1988). 
Studies comparing the conformational stability (AGstab) values of homologous 
enzymes from mesophilic and thermophilic hosts show that the A G stab values of 
enzymes from thermophilic hosts are higher than those of enzymes from 
mesophilic hosts by between 3 and 15 kcal/mol (Nojima et al., 1977, 1978). 
These AGstab values were determined by reversible thermal unfolding 
experiments. Stability studies on mutant enzymes (Shih &Kirsch, 1995; 
Kawamura et al., 1996) have shown that changes in A G stab values as small as 3-
6.5 Kcal/mol can account for thermostability increases of up to 12°C. The AGstab 
values have not been calculated for any enzymes from hyperthermophiles but 
predictions of a AGstab value for a-glucosidase from P.furiosus (Dale & 
McBennett, 1992) suggest that this may be significantly higher than the AGstab 
values for a-glucosidase from a mesophilic host. The difference in AGstab values 
for homologous enzymes from mesophilic, thermophilic and hyperthermophilic 
hosts is a result of differences in specific amino acid sequences, and the 
structures to which these give rise.
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1.4.2 Strategies for investigating thermostability
Two main strategies have been used to investigate enzyme 
thermostability. One is a comparative approach whereby either the amino acid 
sequences or crystal structures of homologous enzymes from mesophilic, 
thermophilic, or hyperthermophilic organisms are compared. Their differing 
thermostabilities can then be attributed these differences, although phylogenetic 
differences can confuse the picture. Several studies have sought to compare the 
sequences of mesophilic and thermophilic enzymes belonging to protein families 
for which a structure was available (Argos et al., 1979; Menendez-Arias & Argos, 
1989; Britton et al., 1995). Suggested preferences in the selection of amino acids 
for thermophilic enzymes included exchanges such as lysine to arginine, glycine / 
serine to alanine, and serine to threonine. However sequence comparisons of 
mesophilic, and thermophilic enzymes are not always consistent with these 
suggestions (Pauptit et al., 1988). Also with sequence comparisons between 
mesophilic and thermophilic enzymes within homologous families, the number of 
sequence changes are generally so numerous that it is difficult to locate those 
that contribute to increased thermostability. Thus analysis of amino acid 
sequence alone is insufficient to allow prediction of features that give rise to 
enhanced thermostability.
The second approach is the use of site directed mutagenesis to create 
mutants to determine their effects on the protein’s thermostability. This second 
approach is often combined with the first to test predictions made by structural / 
amino acid comparisons. One way in which site directed mutagenesis is used to 
investigate thermostability is in the mutation of a mesophilic enzyme to 
incorporate some of the structural features from the thermophilic homologue that 
have been implicated in its thermostability. A number of groups have used this 
approach successfully. Vetriani et al (1998) carried out a structural comparison
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between hexameric glutamate dehydrogenases from the hyperthermophiles 
P.furiosus, and Thermococcus litoralis, which grow optimally at 100°C and 88°C 
respectively, and found that an intersubunit ion pair network was substantially 
reduced in the less stable enzyme from T.litoralis. Two residues were altered by 
site directed mutagenesis to restore these interactions. The single mutations 
both had adverse effects on the thermostability of the enzyme. However with 
both mutations in place to create an ionic interaction, a fourfold improvement in 
stability at 104°C was observed over the wildtype enzyme. Following comparison 
of the amino acid sequences from a thermolysin like protein (TLP) from Bacillus 
stearothermophilus (TLPst) with its more stable counterpart thermolysin (TLN), 
Van den Burg et al (1998) showed that the TLPst, could be made more stable 
than TLN by mutating TLPst to incorporate 5 amino acids that are found in TLN, 
and 3 rationally designed mutations. The advantage of the mutagenesis 
approach is that any amino acid change can be directly attributed to a change in 
stability.
1.4.3 Determinants of thermostability
Jaenicke & Bohm (1998) have reviewed the strategies of thermal 
stabilisation of 8 thermophilic enzymes and reported that in going from lower to 
higher growth temperatures numerous differences are frequently reported: the 
clustering of intrasubunit and/or intersubunit ion pairs; improved packing of the 
hydrophobic core; additional networks of hydrogen bonds, increased helix-dipole 
stabilisation; an increased polar surface area; a decreased number and total 
volume of cavities, and burying the hydrophobic surface area. Querol et al. 
(1996) have also listed a number of different physical and chemical features that 
researchers have reported to explain enhanced thermostabilization in proteins, 
and these include improved hydrogen bonding, better hydrophobic internal 
packing, enhanced secondary structure propensity, helix dipole stabilization,
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removal of residues sensitive to oxidation or deamination, burying of hydrophobic 
accessible area, improved electrostatic interactions, strengthening of the inter­
subunit association, decreased backbone strain, salt bridge optimisation, 
enhanced stability of secondary structures, decreased glycines and increased 
prolines in loops, shorter loops, additional disulphide bridges, decrease in 
number and volume of internal cavities, and an increase in aromatic interactions.
Proteins may be engineered or evolve in vivo to achieve greater stability 
using one or more of these strategies, although no single or preferred method 
has yet been found. A brief description of some of the intrinsic features 
determined to play a role in protein stability is now given.
1.4.3.1 Intrinsic determinants of thermostability
1.4.3.1 a Ionic interactions
The importance of ionic interactions in thermostability has been 
demonstrated by increasing the number of ionic interactions within a protein by 
site directed mutagenesis (Vetriani et al., 1998), see section 1.4.2, and by the 
disruption of ionic networks leading to a decrease in thermostability 
(Pappenberger et al., 1997). Structural comparisons have also highlighted the 
importance of ionic interactions in thermostability (Wallon et al., 1997; Korndorfer 
et al., 1995; Yip et al., 1995, 1998; Russell et al., 1997).
However a number of studies have questioned the importance of ion pair 
networks to thermostability. For example, the replacement by mutagenesis of 
three charged residues that form part of a small ion pair network in the Arc 
repressor by three hydrophobic residues resulted in an increase in stability 
(Waldburger et al., 1995). Furthermore, the comparative structural analysis of 
the neutral protease from Bacillus cereus and the thermostable enzyme
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thermolysin failed to reveal a dramatic increase in the number of ion pairs, 
suggesting that this type of interaction is of little importance in generating stability 
in this enzyme (Pauptit et al., 1988).
1.4.3.1 b Hydrophobic effect
Hydrophobic interactions are often thought to provide the energy required 
for proteins to fold in aqueous solutions. From a study of 72 side-chain aliphatic 
mutations in four enzymes, Pace (1992) calculated that each buried -CH2 group 
contributes an average 1.3 kcal mol'1 to the conformational stability of the 
enzyme. Hydrophobic interactions have been predicted to play a role in protein 
stability from a comparison of the amino acid sequences (Haney et al., 1999) and 
crystal structures of thermophilic enzymes with their mesophilic counterparts 
(Davies et al., 1993; Koralev et al., 1995). The role of hydrophobic interactions in 
stability has also been shown by work on 3-isopropylmalate dehydrogenase; 
when two residues at the dimer interface of the E.coli enzyme (Glu246 and 
Met249) were replaced by the more hydrophobic, homologous residues from 
T.thermophilus IPMDH (Leu246 and Val249) the resulting mutant was stabilised 
against dissociation and denaturation by urea (Imada et al., 1991; Kirino et al.,
1994). Furthermore Rojkova et al. (1999) in work on formate dehydrogenase 
(FDH) from a Pseudomonas sp, showed that the stability of the enzyme could be 
increased 1.5 fold by substituting a-helical residues with more hydrophobic 
residues.
Closely packed aromatic ring-ring interactions in proteins represent a type 
of hydrophobic interaction, and their stabilising potential is approximately 
1 kcal/mol (Burley & Petsko, 1985). A large number of aromatic interactions is 
thought to be one of the stabilizing factors of thermitase from 
Thermoactinomyces vulgaris (Teplyakov et al., 1990).
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1.4.3.1c Hydrogen bonds
In a hydrogen bond, a hydrogen atom is shared by two other 
electronegative atoms. The atom to which the hydrogen is more tightly linked is 
called the hydrogen donor whereas the other atom is the hydrogen acceptor. 
The donor atom in a hydrogen bond is oxygen or a nitrogen that has a covalently 
attached hydrogen atom. The acceptor atom is either oxygen or nitrogen. The 
contribution of hydrogen bonds to a protein’s native state has been investigated 
by disruption of the bonds by mutating one or both of the residues involved in a 
pair. Shirley et al. (1992) carried out thermal and unfolding studies on 12 
mutants of ribonuclease T1 (with disrupted hydrogen bonds), and found that the 
hydrogen bonds made a significant contribution to the protein’s conformational 
stability. An average decrease in stability of 1.3 kcal mol-1 was found per 
hydrogen bond destroyed. Vogt et al. (1997) noticed in their structural 
comparison study of proteins from 16 families that in 80% of the proteins there 
was an average increase of 11.7 hydrogen bonds per chain per 10°C rise in 
stability.
1.4.3.1d Disulphide bonds
A disulphide bond is formed when the sulphydryl groups of two cysteine 
residues are oxidised to produce a cystine residue. Disulphide bonds might be 
expected to stabilise the conformation of a folded protein by forming a physical 
constraint to unfolding. However Wetzel (1987) suggests that disulphide bonds 
actually stabilise by decreasing the degrees of freedom of the unfolded state, 
thus disulphide crosslinks decrease the amount of entropy that can be gained in 
the unfolding reaction. Pace et al. (1988) suggested that a disulphide bridge can 
contribute up to 4 kcal/mol to stability. Attempts at stabilising proteins by 
introducing disulphide bridges have met with mixed success. In many cases 
introduction of a disulphide bridge has resulted in destabilisation of the protein
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(Villafranca et al.,1988; Wetzel et al., 1988). In other cases introduced disulphide 
bridges have been shown to be stabilising. Mansfeld et al. (1997) showed the 
importance of disulphide bridges in thermostability by engineering one into a 
thermolysin-like protease from B.steamthermophilus. The thermostability of the 
mutant was increased significantly (the half life of the double mutant enzyme 
being increased more than 120 fold at 92°C compared with the wildtype enzyme).
1.4.3.1 e Helix Stabilising factors
The a helix is one of two prominent types of secondary structure found in 
globular proteins, and for this reason many studies have concentrated on factors 
that affect helix stability. Facchiano et al. (1998) compared the Xray structures of 
13 thermophilic proteins with their mesophilic counterparts (using a computational 
method to estimate stabilizing contributions associated with helix formation) to 
determine the difference in the stability of their helices. They found that overall 
the helices of thermophilic proteins were more stable than their mesophilic 
homologues in 69% of cases.
Munoz and Serrano (1995) have grouped a-helix stabilising factors into 
sequence motifs (the N-capping box, the hydrophobic staple, the Schellman 
motif, and the alpha L motif, single residue effects (N-capping residue, p- 
branched effects, charge-dipole interaction) and interactions between specific 
pairs of side chains (Lys-Glu, Phe-Cys/Met, hydrophobic effect). The 
modification of these stabilising factors in helices can be used to improve stability 
(Nicholson et al., 1988; Zhukovsky et al., 1994).
Facchiano et al. (1998) however have disputed the importance of some a- 
helical stabilising factors in their study, finding little evidence for the importance of 
the N-capping box, the Schellman, alphaL and hydrophobic staple motifs, and
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concluded that these factors were not related to the stability of thermophilic 
proteins, although they did not exclude the fact that they could play a stabilising 
role in specific cases.
1.4.3.1f Reduction in the entropy of unfolding
Mathews et al. (1987) proposed that proteins could be stabilised by 
decreasing the entropy of their unfolded state. In the unfolded state Gly is the 
residue with the highest conformational entropy and in the folding process much 
more energy is required to restrict the conformation of Gly than any other residue. 
Pro residues, with their pyrrolidine ring, can only form a few configurations and 
they restrict the configurations allowed for the preceding residue. Thus by 
substituting any other residue for Gly (or Pro for any other residue) one should 
reduce the entropy of the unfolded state. However, for such a mutation to 
stabilise the folded protein, its location should be carefully chosen so as not to 
reduce any noncovalent interactions and to ensure a similar conformation to the 
residue that was replaced. Mathews et al. (1987) replaced glycine residues with 
alanine residues to reduce the entropy of unfolded T4 lysozyme, and found these 
mutations stabilised the protein.
The effect of Pro residues on protein stabilisation has been studied by site 
directed mutagenesis in T4 lysozyme. Mathews et al. (1987) made a Lys-Pro 
substitution in T4 lysozyme which was stabilising. They also made an lle-Pro 
substition in T4 lysozyme which reduced the stability of the protein. It was 
thought that this was because the lle-Pro mutation created a cavity in the 
molecule, with a resulting loss of van der Waals interactions (Dixon et al., 1992). 
The degree of enthalpic destabilisation in the lle-Pro mutant was greater than the 
degree of entropy gained by introducing the Pro residue, therefore the mutation 
was destabilising.
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1.4.3.1g Resistance to covalent destruction.
Irreversible enzyme denaturation by temperature induced covalent 
modifications (i.e. cysteine destruction, asparagine and glutamine deamidation 
and the hydrolysis of peptide bonds [Volkin & Middaugh, 1992]) becomes 
significant only at elevated temperatures. In their studies of a-amylases Tomazic 
& Klibanov, (1988), showed that the enzymes from Bacillus amyloliquefaciens 
and Bacillus stearothermophilus were inactivated by unfolding, while deamidation 
was responsible for inactivating the more rigid, and more stable enzyme from 
Bacillus licheniformis. Hensel et al. (1993) investigated glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) from a thermophile and a hyperthermophile, 
and concluded that the hyperthermophilic GAPDH had a greater resistance to 
covalent modification than the thermophilic GAPDH.
Cysteine residues, which have the potential to form disulphide bridges 
and which have been shown to stabilise thermophile enzymes at temperatures 
up to 60-80°C (Matsumara et al., 1989), are often absent in enzymes isolated 
from hyperthermophiles (Volkin & Klibanov, 1987; Burley & Petsko, 1985; Russell 
et al., 1997). Gin and Asn residues are also reduced in number and or buried 
from solvent in hyperthermophilic enzymes compared to their mesophilic 
counterparts (Russell et al., 1997).
1.4.3.1 h Stabilisation of loops/reduction in flexibility
Loops are believed to be important in protein stability as they might 
provide initiation points for unfolding (Leszczynski & Rose, 1986). Consequently, 
one might expect to find shorter loops in thermophilic enzymes. This has been 
observed in the structural comparison of IPMDH from two mesophiles and a 
thermophile (Wallon et al.,1997). In the comparison of the crystal structures of 
CS from a mesophile and a thermophile (Russell et al., 1994), four loops present
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in pig CS are absent in 7pCS, and other loops located next to highly flexible a- 
helices in pig CS are shortened in TpCS. PfCS has the same four shortened 
loops, and a further two loops that are significantly shorter compared to pig CS. 
It is believed that these changes increase the compactness of a protein reducing 
its flexibility.
1.4.3.2 Extrinsic determinants of thermostability
All of the previously described thermostabilising features are of an 
intrinsic nature. However, in some cases where a hyperthermophilic enzyme has 
been expressed in a mesophilic host, the recombinant protein has a decreased 
stability to temperature and pressure (Purcarea et al., 1997). Such observations 
indicate that some extrinsic factors play a role in protein stability in vivo.
It is thought that some hyperthermophilic Archaea accumulate compatible 
organic solutes at high temperatures. For example, P.furiosus (Martins & Santos,
1995), and Methanococcus igneus (Ciulla et al., 1994) both accumulate di-myo- 
inositol-I.IXS^-phosphate under such conditions, and other Archaea 
accumulate cyclic-2,3-bisphosphoglycerate (Hensel & Konig, 1988), or trehalose 
(Martins et al., 1997). It is thought that these solutes may have a role as 
intracellular thermoprotectants, and there is evidence that they have a direct 
effect on enzyme stability (Hensel, 1993; Ramos et al., 1997). Additionally, the 
stability of enzymes in vitro is often increased in the presence of ligands, 
suggesting another mechanism of in vivo stabilisation. This has been observed 
in our group where the presence of citrate enhances the thermostability of citrate 
synthases.
Another extrinsic determinant of thermostability is pressure. A number of 
groups have investigated the effects of pressure on the thermostability of proteins
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from organisms from a range of habitats. Athes et al. (1997) found that moderate 
pressures of between 50-250Mpa exerted a protective effect against thermal 
denaturation for three p galactosidases tested. Michels & Clark (1997) found that 
the thermostability and activity of a protease from Methanococcus jannaschii, an 
extremely thermophilic deep sea methanogen, was greatly affected by pressure. 
When they raised the ambient pressure to 500MPa the reaction rate at 125°C 
increased 3.4 fold and the thermostability 2.7 fold. Summit et al. (1998) 
postulated that stabilization by pressure may result from pressure effects on 
thermal unfolding or pressure retardation of unimolecular inactivation of the 
unfolded state.
1.5 Citrate Synthase: a case study;
To identify potential thermostabilising features of CS from the Archaea Russell et 
al. (1997) compared the structures of CS from a mesophile (pig, 37°C), a 
thermophile (T.acidophilum, 60°C) and a hyperthermophile (P.furiosus, 100°C). 
Fig 1.5, an a carbon trace (orthogonal view) of CS from pig, Tp, and Pf, shows 
the strong structural homology between CS from Pf, Tp and pig despite their 
amino acid sequence differences (PfCS exhibits 30% and 42% identity to pig and 
TpCS respectively).Given the overall similarity in the folds, active sites and 
subunit interfaces of the CS’s it has been possible to observe trends in the CS 
structure moving from a mesophilic CS to a thermophilic CS, and to 
hyperthermophilic CS. The most significant of these are an increased 
compactness of the enzyme, a more intimate association of the subunits, an 
increase in the number of intersubunit ion pairs, and a reduction in the number of 
thermolabile residues. This comparison has taken into account the fact that the 
structure of TpCS is in the open form (ligand free) while the other structures were 
elucidated from the closed form (ligand bound).
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Increased compactness: TpCS has four loops that are significantly shorter than 
the corresponding loops in pig CS; PfCS has the same four shortened loops, and 
a further two loops that are significantly shorter compared to pig CS. Figure 1.6 
shows a schematic representation of the loop region of pig, Tp and PfCS 
between helices B and C. One can see from this figure that there is a reduction 
in loop size from the pig to Tp to PfCS. As one goes up the temperature scale 
there are also fewer cavities. Cavities exist in virtually all large proteins and may 
be required to make the protein functional by reducing the strains caused by 
dense packing of the hydrophobic side chains. Cavity filling studies have shown 
that cavities are a source of instability within a protein (Akasako et al., 1997; 
Ishikawa et al., 1993). TpCS has only 3 cavities compared to 7 in pig while PfCS 
had none. Thus the absence of large cavities in PfCS may contribute to its 
thermostability by eliminating areas in the structure where non-optimal packing 
occurs. PfCS has also a reduced accessible surface area and volume compared 
to pig CS and the percentage of atoms buried is greater. These differences are 
not just because of the 35 amino acid N-terminal extension in pig CS since 
identical calculations for an N-terminally deleted (35 residue) pigCS shows that 
PfCS is still more compact.
Improved monomer-monomer association: In PfCS the monomer- 
monomer association is made up of two parts: the 8 a-helical sandwich, which is 
the main component, and the interaction of the C-terminus of one monomer with 
the partner subunit. The complementarity of packing can be viewed by way of a 
gap volume index, defined as the interface gap volume divided by the interface 
surface accessible area (Jones and Thornton., 1995). The gap volume index for 
pig is 1.86 A , while that for TpCS is 1.10 A and for PfCS is 1.17 A, a smaller 
figure being indicative of closer packing. However, in the 3D structure of the
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Figure 1.5 Ribbon diagrams of an orthogonal view of pigCS, TpCS, 
PfCS. Pig CS is coloured in blue, TpCS in gold and PfCS in red.
and
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open form of TpCS the final 14 C-terminal residues are missing, and if a gap 
volume index is recalculated for a 14 C-terminal deleted PfCS, then a figure of
1.02 A is obtained. This improved complementarity may allow the two monomers 
to remain in an intact dimer at high temperatures through optimised packing 
interactions.
In addition to the improved complementarity the interactions at the subunit 
interface in PfCS are strengthened through an increased number of intersubunit 
ionic interactions within the 8 a-helical sandwich region. Using a cut-off distance 
of 4 A there are no ion pairs in pigCS in this intersubunit region, while in TpCS 
there is one ion pair. At the subunit interface of P.furiosus, however, there are 5 
residues that make up a 5 membered ionic ring network at either end of helices G 
and M. Further details of this network are given in the introduction to chapter 
five.
In PfCS the C-terminus of one monomer embraces the N-terminus of the 
other monomer, and this interaction is thought to be anchored by an ionic 
interaction between residues Glu48-Arg375\ There are no similar interactions 
observed in pig or TpCS, although until a closed structure is obtained for TpCS 
this type of interaction cannot be ruled out (further details of the C-terminal 
interaction are given in the introduction to chapter 4). A calculation of the number 
of hydrogen bonds for the 3 enzymes showed that there was no significant 
difference in hydrogen bonding between the three enzymes. However there is a 
significant increase in the number of intersubunit hydrogen bonds for PfCS (51) 
compared with pigCS (40).
Increased number of ionic bonds: When the total number of ion pairs 
was calculated for pigCS, TpCS, and PfCS, using cut off distances between 
oppositely charged residues of 4, 5 and 6 A, there was observed to be a
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significantly increased number of total ion pairs found in PfCS compared with 
TpCS, and pigCS (see Table 1.1). There is also a significantly greater number of 
intersubunit ionic bonds in PfCS than in pig CS or TpCS.
Ion Pairs in Citrate Synthase
pigCS TpCS PfCS
6 A Cut-off
Total ion pairs 82 90 105
Intra ion pairs in A 35 39 42
Intra ion pairs in B 35 41 39
Inter A to B- 12 10 24
5 A Cut-off
Total ion pairs 64 65 69
Intra ion pairs in A 26 30 25
Intra ion pairs in B 26 29 24
Inter A to B- 12 6 20
4 A Cut-off
Total ion pairs 36 43 43
Intra ion pairs in A 12 21 14
Intra ion pairs in B 12 18 12
Inter A to B- 12 4 17
Table 1.1 The number of ion pairs in CS from pig, Tp, and Pf, using a 6, 
5, and 4 A cut-off distance between charged groups. A and B refer to the 
two monomers of the native dimer
A number of ion pairs in PfCS are located in loop regions, so that in non­
helical regions of the hyperthermostable enzyme ion pairs help to stabilize these 
flexible regions, in addition to loop stabilization via shortening. Fig 1.7 shows the 
ionic interactions present in loop regions of CS from pig, Tp, and Pf.
Fewer thermolabile residues: of the 20 amino acid residues, four (Asn, 
Gin, Met, and Cys) may be classified as thermolabile due to their tendency to 
undergo deamidation or oxidation at high temperatures. Many of the thermolabile 
residues found in pigCS are replaced in PfCS by a residue that forms part of an
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Figure 1.6 Schematic representation of the loop region of pig CS, TpCS 
and PfCS between helices B and C. The pig CS loop is coloured in blue, 





Figure 1.7 Ionic interactions present in the loop regions of CS from pig, 
Tp, and Pf. The blue and red dots indicate positively and negatively 
charged residues respectively.
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ion pair, also some thermolabile residues are eliminated via loop shortening. 
PfCS thus has fewer thermolabile residues than TpCS, which in turn has fewer 
than pigCS. PfCS has fewer Met residues than either pig or TpCS and the Met 
residues that it has are all effectively buried from solvent. Similarly PfCS has 
only 5 Asn residues exposed to solvent as opposed to 13 and 14 for pig and 
TpCS, respectively. PfCS has only 5 Gin as opposed to 10 and 17 Gin residues 
in TpCS and pig CS, respectively.
Isoleucine Clusters: a significant increase in the number of isoleucine 
residues is observed in PfCS compared with pigCS and DS23r, see Fig 1.8. 
These substitutions result in the formation of isoleucine clusters sandwiched 
between the intersubunit helices (F, G, L, and M) and between helices I and S in 
each monomer. This clustering of isoleucine residues allows for a very well 
packed hydrophobic core of the protein. A similar clustering is observed in 
glutamate dehydrogenase from P.furiosus and has been implicated in the 




Figure 1.8 Isoleucine residues present in CS from, DS23r, pig and PfCS.
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1.6 Other Detailed Comparisons
A number of other groups have carried out structural comparison studies 
(Wallon et al., 1997; Vogt et al., 1997; Yip et al., 1995,1998). Wallon et al. (1997) 
compared the structures of 3-iospropylmalate dehydrogenase (IPMDH) from two 
mesophiles, Escherichia coli and Salmonella typhimurium, with their thermophilic 
counterpart from Thermus thermophilus, to elucidate the basis of the higher 
thermostability of the T.thermophilus enzyme. They predicted from this 
comparison that the main stabilising features in the thermophilic enzyme were an 
increased number of salt bridges, additional hydrogen bonds, a proportionately 
larger and more hydrophobic subunit interface, shortened N and C termini, and a 
larger number of proline residues
Vogt et al., (1997) compared 16 families of proteins with different 
thermostabilities, including subtilisin, glyceraldehyde 3-phosphate 
dehydrogenase, and lactate dehydrogenase. The proteins were compared on 
the basis of their respective fractional polar atom surface areas, and the number 
and type of hydrogen bonds and salt links between explicit protein atoms. In over 
80% of the families studied, correlations were found between the thermostability 
of the familial members and an increase in the numbers of hydrogen bonds, as 
well as an increase in the fractional polar surface which results in added 
hydrogen bonded density to water. The number of ion pairs were also found to 
increase in two-thirds of the families tested.
In their study of the structure of glutamate dehydrogenase (GluDH) from 
the hyperthermophile P.furiosus, Yip et al. (1995) observed that this structure 
contained a number of ion pair networks, not found in the equivalent mesophilic 
enzyme (Rice et al., 1996). These were proposed to be involved in maintaining
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stability at high temperatures. From this comparison of the structure of Pf GluDH 
with those of mesophilic GluDH’s from E.coli and Clostridium symbiosum, Yip et 
al. (1998) then went on to determine the amino acid sequence similarity between 
the Pf GluDH and other members of the GluDH family, from species which span 
a wide range of optimum growth temperatures. The results of this analysis 
indicated that the ion pair networks became more fragmented as the enzyme 
stability decreased. These findings were consistent with the role of ion pair 
networks in the adaptation of enzymes to extreme temperatures.
A problem with the comparative approach is that it is suggestive but does 
not actually prove whether features predicted to be responsible for an enzyme’s 
thermostability, actually are. Therefore this approach is most useful when it is 
combined with site directed mutagenesis.
1.7 Are there general rules for protein thermostability ?
On the basis of comparative studies of the primary structures of proteins 
from mesophilic and thermophilic organisms general “rules” for stability have 
been proposed (Argos et al., 1979; Menendez-Arias & Argos, 1989). Mutational 
studies however have shown that many of these purely statistical rules do not 
apply and the effects of site directed mutations need to be evaluated in a context 
dependent way. From the work of Van Den Berg et al. (1998) it appears that 
improvements in thermostability are additive, and that a very small number of 
changes to a molecule can dramatically alter its thermostability, but these are 
very site specific. Usher et al. (1998) echo this view stating that an improvement 
in thermostability is as a result of small changes such as an increase in the 
number of proline residues and that no single factor predominates. Jaenicke & 
Bohm (1998) view proteins as ‘individuals’ that accumulate increments of
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stabilization; in thermophiles these come from charge clusters, networks of
t
hydrogen bonds, optimization of packing and hydrophobic interactions.
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1.8 Aims and Objectives
The aim of this project was to investigate the structural factors that 
determine protein thermostability in CS from the Archaea. The genes encoding 
the citrate synthase from the archaea P.furiosus and T.acidophilum have 
previously been cloned, sequenced and expressed in our research group, and 
the 3D crystal structures have been determined.
From structural comparisons of the CS’s from a psychrophile to a 
hyperthermophile (Russell et al., 1997, 1998) it has been possible to observe 
trends in the CS structures as one moves up the temperature scale, and to make 
predictions as to the determinants of thermostability.
The work that is presented here falls into two main areas:
1) The swapping of the small domains between 7pCS and PfCS to 
produce chimaeric synthases. Analysis of these mutants will provide information 
on the relative contributions to thermostability and catalytic activity of each 
domain.
2) Mutation of structural regions within the large domain of PfCS that 
were predicted to play a role in the thermostability of PfCS (from the crystal 
structure of PfCS).
Analysis of these mutants will test the predictions of thermostabilising 




This chapter details the general techniques used in the experiments 
described in this thesis. Methods that are specific to a particular chapter are 
described within that chapter.
2.1. Reagents, enzymes and other materials
Molecular Biology: Taq DNA polymerase, T4 polynucleotide kinase,
T4 DNA Ligase, and the Rapid Ligase Kit were supplied by Boehringer 
Mannheim, (Mannheim, Germany). Lysozyme, RNAse A, and phenol: 
chloroform: isoamyl alcohol (25:24:1) were supplied by Sigma Aldrich Chemical 
Company, (Poole, UK). Restriction enzymes were supplied by New England 
Biolabs, (Boston, USA). Oligonucleotides were supplied by Perkin Elmer 
Biosystems Ltd., (Warrington, UK). Geneclean® III DNA purification kits were 
obtained from Bio 101 Inc, (La Jolla, USA). The Altered Sites ll®mutagenesis kit 
was supplied by Promega UK Ltd., (Southampton, UK). Quiagen DNA 
purification kit™ was supplied by Quiagen Ltd., (Crawley, UK). The Snap 
Miniprep Kit™ was supplied by Invitrogen, (Carlsbad, USA). Ready To Go™ 
PCR beads were supplied by Amersham Pharmacia Biotech Ltd, (St Albans, 
UK)
Cell culture: Bacteriological peptone was supplied by Oxoid Ltd,
(Basingstoke UK). Bacto-agar, yeast extract and tryptone were supplied by
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Difco Laboratories Ltd., (Detroit, USA). Tetracycline, nalidixic acid, and 
ampicillin (sodium salt) were supplied by the Sigma Aldrich Chemical Company, 
(Poole, UK). X-Gal, and IPTG were supplied by the Calbiochem-Novabiochem 
Corporation, (La Jolla, USA)
Electrophoresis: Low melting point agarose, standard agarose,
ethidium bromide, and TEMED were obtained from Sigma Aldrich Chemical 
Company, (Poole, UK). Lambda Hindlll DNA markers and 1 kb ladder were 
supplied by Life Technologies Ltd, (Paisley UK). Pst-I digested lambda DNA, 
was obtained from Northumbria Biologicals Ltd., (Cramlington, UK). Ammonium 
persulphate, broad, and low range protein standards were supplied by Bio-rad 
Laboratories Ltd., (Hemel Hempsted, UK). Protogel™ acrylamide stock solution 
was supplied by National Diagnostics, (Georgia USA). BioDesign GelWrap ™ 
was supplied by BioDesign Inc., ( New York, USA)
CS purification and assay: Dye matrex red gel A was supplied by
Millipore UK Ltd., (Watford, UK). PD-10 Sephadex G-25M columns were 
supplied by Amersham Pharmacia Biotech Ltd, (St Albans, UK). Amicon 
centriplus concentrators were supplied by Amicon, (Beverley, USA). Vivaspin 
15ml concentrators were supplied by Vivascience, (Lincoln, UK). BSA, 
Coomassie Brilliant Blue G-250, Coomassie Brilliant Blue R, Coenzyme A 
(lithium salt from yeast), and oxaloacetic acid, were supplied by the Sigma 
Aldrich Chemical Company, (Poole, UK). PMSF was supplied by Fluka 
Chemicals (Gillingham, UK). DTNB was supplied by ICN ImmunoBiologicals, 
(Lisle, USA). 3MM paper was supplied by Whatman Scientific Ltd.,(Maidstone, 
UK). Polyethylene glycol grade 400 was supplied by Fisher Scientific Ltd., 
(Loughborough, UK).
All of the other chemicals used were supplied by Fisons, (Loughborough,
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UK), Sigma Aldrich Chemical Company (Poole, UK), Fluka Chemicals, 
(Gillingham, UK), and Merck, (Lutterworth, UK).
Bacterial strains, culture conditions and plasmids
The E.coli strains JM109 (end A1, recA1, gyr A96, thi, hsdR17 (rk-, mk+), 
relA1, supE44, X-, A (lac-proAB), [F\ traD36, proAB, laclq ZAM15]); and DH5a 
(Sup E44, A lac U169, (<|) 80 lac Z M15), hsdR17, recA1, end A1, gyr A96, thi-1, 
relA1); MOB154 (gltA6, galK30, pyrD36, relA1, rpsL129, thi-1 supE44, hsdR4, 
recA X- [Wood et al., 1983]), were grown in LB broth, 1.0% (w/v) Bacto tryptone, 
0.5% (w/v) yeast extract, and 1.0% (w/v) NaCI) at 37°C, shaking at 200 rpm, or 
on LB plates, 1.5% (w/v) Bacto agar at 37°C. For the growth of E.coli strains 
carrying plasmids conferring ampicillin resistance, media were supplemented 
with ampicillin to give a final concentration of 125pg/ml. Bacterial strains 
expressing tetracycline resistance genes were grown in media and on plates 
supplemented with 15pg/ml of tetracycline. All bacterial strains were stored as 
glycerol stocks (24% v/v) at -70°C.
The plasmids pUC19 and pKK223-3 were obtained from Amersham 
Pharmacia Biotech Ltd. The pALTER-1 mutagenesis vector came with the 
Altered Sites II mutagenesis kit™. The pREC7 NDE vector was kindly supplied 
by Linda Kurtz of Washington University School of Medicine, (St Louis, USA).
2.2 Molecular Biology Methods
2.2.1 Small scale preparation of plasmid DNA -’Miniprep*
E.coli strains containing the plasmid of interest were cultured overnight in 
1.5ml of LB (containing the appropriate selective antibiotic). Plasmid DNA was
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then prepared by a method based on the alkaline lysis method (as described by 
Sambrook et al.,1989). The overnight culture was centrifuged at 13000 x g for 5 
min, the supernatant discarded, and the cells resuspended in 150^1 of pre­
chilled lysis buffer (50 mM glucose, 10 mM EDTA, 25 mM Tris-HC, pH 8.0). A 
200pl volume of 0.2 M NaOH, 1% (w/v) SDS was added and the cells left on ice 
for 5 min. Then a 200 nl volume of 3M potassium acetate, pH 4.5 was added, 
and the precipitate removed by centrifugation at 13000 x g for 10 min. The 
supernatant was extracted twice with an equal volume of 25:24:1 (v:v:v) 
phenol:chloroform:isoamyl alcohol and the DNA precipitated with ethanol. The 
DNA was then resuspended in 25pJ of double distilled water.
A Snap Miniprep Kit™ was also used for the ‘mini’ preparation of 
plasmid DNA. The manufacturers’ instructions supplied with the kit were 
followed.
2.2.2 Large scale preparation of plasmid DNA -’Maxiprep’
This method is based on that described by Ausubel et al. (1987). E.coli 
cells containing the plasmid of interest were cultured in 100ml of LB (containing 
an appropriate antibiotic) overnight on an orbital shaker at 37°C. The culture 
was spun down at 6000 x g for 10 min. The pellet was resuspended in 4ml of 
50mM Tris-HCI, pH 8.0, 10mM EDTA, 100 ng/ml RNAse A. A 4ml volume of 
200mM NaOH, 1% SDS (v/v) was added and incubated at room temperature for 
5 min (mixture being inverted several times to ensure good mixing). A 4ml 
volume of chilled 3.0 M potassium acetate, pH 5.5, was added and left on ice for 
15 min. The solution was spun in a Sorvall rotor at 13000 x g for 30 min at 4°C, 
the supernatant was then transferred to a clean Corex tube and spun for a 
further 15 min at 13000 x g. The final supernatant was then loaded onto a
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Quiagen™ column -100 (pre-equilibrated with 4 ml of 750 mM NaCI, 50mM 
MOPS, pH 7.0, 15 % ethanol, 0.15% Triton X-100). The column was washed 
with 2x 10ml of 1.0M NaCI, 50 mM MOPS, pH 7.0, 15% ethanol. DNA was 
eluted from the column with 5ml of 1.25M NaCI, 50 mM Tris-HCI, pH 8.5. DNA 
was precipitated by the addition of 0.7 volumes of isopropanol at room 
temperature. The microfuge tubes were spun at 13000 x g for 30 min at 4°C, 
the supernatant was discarded, and the DNA pellets were washed twice with 
1.5ml of 70% (v/v) ethanol. The microfuge tubes were air dried under vacuum in 
a rotary evaporator for 5 min before the DNA was redissolved in 80pl of 1 x TE 
buffer, pH 8.0.
2.2.3 Precipitation of DNA
Ethanol precipitation was used to concentrate a DNA sample, or to bring 
about a buffer exchange. DNA was precipitated by adding 3M sodium acetate 
pH 5.2, to give a final concentration of 0.3M, and three volumes of prechilled 
absolute ethanol. The sample was left in a beaker of dry ice for 5 min before 
being spun at 13000 x g for 10 min. The DNA pellet was washed twice with 
70% (v/v) ethanol and air dried under vacuum in a rotary evaporator for 5 min 
before being redissolved in an appropriate volume of buffer.
2.2.4 Determining the concentration and purity of DNA
The concentration of a solution of DNA was determined by measuring 
the absorbance at 260 nm (Sambrook et al., 1989). A 50pg/ml solution of 
double stranded DNA has an absorbance of 1 unit at 260 nm. Purity of a DNA 
sample was assessed by calculating the A260/A280 ratio of the sample. A ratio of 
1.75 or more indicated that the DNA sample was pure.
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2.2.5 Restriction Digestion of DNA
Restriction digestion was carried out in accordance with the enzyme 
manufacturer’s instructions. The incubation time and the number of units of 
enzyme used were varied depending on the amount of DNA being cut. When 
double digests were carried out, restriction buffers that were compatible with 
both enzymes were chosen. If the restriction buffers of two enzymes in a 
double digest were incompatible, then the DNA was cut first with one enzyme, 
the DNA precipitated to remove the buffer, and resuspended in double distilled 
water, before being digested with the second enzyme. When restricting DNA 
prepared by the ‘miniprep’ method, DNAse-free RNAse A was added to a 
concentration of 0.1 mg/ml, for the last 30 min of the restriction digestion.
2.2.6 5' Phosphorylation of Oligonucleotides
100pmoles of oligonucleotide were phosphorylated by the addition of 5 
units of T4 polynucleotide kinase, X10 kinase buffer, 1mM ATP, and sterile 
distilled water to a final volume of 25pl . Each reaction was incubated at 37°C 
for 30 min, and was stopped by heating at 70°C for 10 min. Phosphorylated 
oligonucleotide was stored at -20°C
2.2.7 DNA Ligation
Ligations were carried out in a final volume of 30pl. The insert to vector 
ratio varied between 3-5:1. The ligations were incubated either at room 
temperature for 1 hour followed by 37°C for 1 hour, or overnight at 15°C. Each 
reaction contained 4 units of ligase and 3pl of 10 x ligase buffer. Controls: 1) 
no ligase and no insert (checks for uncut vector DNA), 2) no insert (checks for 
vector religation).
40
2.2.8 Transformation of Competent cells.
Bacterial cells were made competent and transformed with double 
stranded DNA using the calcium chloride method. A 250pl volume of an 
overnight culture of cells was used to inoculate 20ml of LB media in a 50ml 
Falcon tube. This was incubated at 37°C, shaking at 200 rpm in an incubator. 
After 2-3 hours, when the A6oo was between 0.3-0.5, the cells were spun down 
at 3000 x g for 10 min. The supernatant was discarded and the cells were 
resuspended in 1ml of ice cold 50mM CaCI2, and were then left on ice for a 
minimum of 15 min prior to starting the transformation.
200(4.1 of freshly-prepared competent cells were used in each 
transformation reaction. DNA, either from a ligation reaction or uncut, was 
added to the competent cells and left on ice for a minimum of 30 min, before 
being heat shocked in a water bath at 42°C for 45 sec. The cells were placed 
on ice for 2 min before being aliquotted into 1ml of LB in a 10ml Falcon tube. 
The cells were incubated at 37°C at 200 rpm in an incubator for 90 min before 
200jliI of cells were plated onto LB plates containing the appropriate 
supplements. As a control, no vector DNA was added to the competent cells to 
check for contamination. The plates were incubated overnight at 37°C and 
transformed colonies selected. (Modified from Sambrook et al., 1989).
2.2.9 Agarose gel electrophoresis
Horizontal agarose gel electrophoresis was used for purification and 
analysis of small DNA fragments. A 1% (w/v) agarose gel gave efficient 
separation of linear, duplex DNA of 0.5-8.0 kb. Agarose was dissolved in 1 x 
TAE buffer (40mM Tris-acetate, pH 8, 1 mM EDTA) by heating in a microwave 
oven. When the agarose had cooled to approximately 45°C, ethidium bromide
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was added to a concentration of 0.5pg/ml. The agarose was then poured into a 
gel mould, a well forming comb clamped into place and the gel left at room 
temperature to set. Once set, the comb was removed and the gel placed in a 
gel tank and covered with 1 x TAE buffer. DNA samples in 1 x loading buffer 
(0.04 %(w/v) bromophenol blue, 0.04 %(w/v) xylene cyanol, 5 % (v/v) glycerol), 
were loaded into the wells, and electrophoresed at a constant voltage of 100 V 
until the xylene cyanol dye front was 1 cm from the edge of the gel. The size 
separated DNA was then visualised under UV illumination. Markers used 
included 1 kb ladder, and Hindlll and Pst-I digested X DNA. When a DNA band 
was to be cut out from an agarose gel, a 1% low melting point agarose gel was 
used.
2.2.10 DNA purification from agarose gels
Following horizontal gel electrophoresis, the relevant band was 
visualised using a UV transilluminator and excised from the gel using a scalpel.
The DNA was then purified from the gel using a Gene Clean® III Kit. This works
in the following manner. The volume of the gel slice containing the DNA is 
calculated and 3 X this volume of Nal is added to the gel slice. DNA and 
agarose are highly soluble in Nal. Silica beads (glass milk) are then added to 
the solution. DNA has a high affinity for the silica beads at alkaline pH’s but 
RNA and proteins do not bind and are therefore eliminated during subsequent 
washing steps with an ethanol based buffer. DNA is unbound from the silica 
beads by the addition of water or a low salt tris buffer (pH 8.0).
2.2.11 Polymerase Chain Reaction (PCR)
Reactions were carried out in 0.5ml Eppendorf tubes, which were placed 
in a Perkin Elmer Applied Biosystems Cetus thermal PCR machine. The PCR
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reaction mix contained 12pmoles of a forward and a reverse primer, MgCb (at 
concentrations which varied from 1-6mM), 1 unit of Taq (unless otherwise 
stated) polymerase, X10 polymerase buffer (supplied with the polymerase), the 
target DNA to be amplified (0.1 pg), and 50 i^M of each dNTP, unless otherwise 
stated. Each reaction was made up to a final volume of 100jn.f with sterile 
distilled water, and the PCR mix was covered with 50pl of mineral oil to stop 
evaporation. The PCR machine was programmed to heat for 2 min at 94°C, and 
then 30 cycles of the following conditions:
94°C for 45 sec (denaturing)
55°C for 2 min (annealing)
72°C for 90 sec (extension)
72°C for 10 min (final step after 30 cycles). This was
followed by a cooling step of 4°C until the samples were retrieved for analysis. 
Where the PCR conditions were different, details are given in the relevant 
chapters. Samples of the PCR products were taken, bromophenol blue dye 
added, and the products run on a 1% (w/v) agarose minigel.
Ready To Go™ PCR beads were also used instead of Taq polymerase. 
0.1 fig of template DNA and 12 pmoles of each primer were added to each 0.5 
ml Eppendorf tube. Sterile distilled water was added to give a final volume of 
25]ul. Each reaction was overlaid with 50(xl of mineral oil.
2.2.12 DNA Sequencing
DNA was sequenced using the Perkin Elmer ABI prism 377 Automated 
DNA Sequencer. Samples were prepared for sequencing by aliquotting 0.5^g
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of ‘maxiprep’ DNA (or Snap miniprep purified DNA), and 3 pmoles of 
oligonucleotide primer into an 0.5ml microfuge tube. The volume was made up 
to 12pl using sterile distilled water. Each reaction was covered with 40pl of 
mineral oil. Samples were elongated using T7 DNA polymerase and fluorescent 
labels.
2.2.13 Software
The Wisconsin GCG Sequence Analysis software package was used to 
find unique restriction sites within PfCS and TpCS. The O programme (Jones et 
al.,1991) was used for looking at the crystal structures of PfCS and TpCS. The 
DNA sequence analysis package produced in association with the Perkin Elmer 
Biosystems ABI prism 377 Automated DNA Sequencer was used for interpreting 
the results from the automatic sequencer. The Enzpack Version 3 programme, 
written by P. A Williams and B.N. Zaba, School of Biological Sciences, 
University College of North Wales, Bangor, UK., was used for kinetic analysis of 
data from enzyme assays. In the case of substrate inhibition the Micro Math® 
Scientist® for Windows™ programme was used for analysing the kinetic data.
2.3 Biochemical Techniques
2.3.1 Determination of protein concentration
Protein concentration was determined by the method of Bradford (1976). 
A 0.9ml volume of filtered Bradford reagent, 0.01%(w/v) Coomassie G-250, 
4.8%(v/v) ethanol, 8.5%(v/v) H3PO4, was incubated with a 0.1ml volume of 
protein sample at room temperature for 10 min. The absorbance at 595 nm was 
measured and the protein concentration calculated from a calibration curve 
prepared with BSA standard solutions (0 - 25 pg/ml)
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2.3.2 Protein Expression
A 50ml Falcon tube containing 25 ml of LB (containing ampicillin at a 
concentration of 125pg/ml) was inoculated with a single colony from a plate. 
This culture was incubated overnight at 37°C on a shaking incubator at 200rpm. 
The following day this culture was used to inoculate two 1 litre flasks, each 
containing 500 ml of LB (ampillin 125pg/ml). This was incubated at 37°C on a 
shaking incubator overnight and the following day a compound was added to 
induce expression of protein; the incubation then continued for a further 24 
hours. The inducing compound added depended on the vector that host cells 
contained. For example, if the vector was pRec7-Nde1 based the inducer 
added was nalidixic acid to a concentration of 50jxg/ml. After 24 hours of 
induction the cells were harvested by spinning in GSA rotor at 8000 x g.
2.3.3 Preparation of cell extracts
An overnight culture of E.coli cells, ranging in volume from 10ml-1 litre, 
was centrifuged at 6000 x g for 10 min in a Sorvall GSA rotor at 4°C. The 
supernatant was discarded and the cells were resuspended in pre-chilled 2 x TE 
buffer, pH 8.0, 1 mM PMSF, at a cell density of 0.2g cells /ml . The cells were 
sonicated on ice in 20 second bursts with 30 second intervals, five times. The 
cell debris was removed by centrifugation at 13000 x g for 20 min at 4°C, in a 
Sorvall SS34 rotor. The supernatant was stored at 4°C.
2.3.4 Protein purification
The prepared cell extracts were subjected to a heat step (see respective 
experiments), followed by centrifugation at 13000 x g for 20 min. Each extract 
was then loaded either onto a 1ml, or 30ml, Matrex Gel Red A column, 
equilibrated with 50mM Tris-HCI, pH 8, 2mM EDTA. In large scale CS
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purifications unbound protein was removed by washing the column with loading 
buffer until the A 260 nm baseline returned to zero. In small scale purifications,
unbound protein was removed by washing the column with loading buffer, using 
3 X the volume of sample loaded onto the column. Citrate synthase was eluted 
with loading buffer containing 5mM oxaloacetate and 1mM CoA (James et al., 
1994). Eluted fractions were assayed for CS activity, and samples were run on 
a 10% (w/v) SDS-PAGE gel to check for purity. The pure CS fractions were 
pooled. To remove Ac-CoA and oxaloacetate from the purified enzyme, the 
pooled fraction was buffer exchanged into 50mM phosphate, pH7.2, 2mM 
EDTA, using a PD-10 Sephadex G-25M column. The sample was then 
concentrated using either an Amicon centriplus concentrator, or a Vivascience 
15ml Vivaspin concentrator.
2.3.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)
Protein samples were analysed by the SDS-PAGE method (Laemmli, 
1970). A 20ml resolving gel solution (10% (w/v) Protogel acrylamide, 0.375M 
Tris-HCI pH 8.9, 0.1% (w/v) SDS) was polymerised by the addition of 5 mg of 
ammonium persulphate (from a 10% (w/v) solution), and 20pl of TEMED, and 
poured into a gel mould. The gel solution was overlaid with water-saturated n- 
butanol and left to polymerise at room temperature. The n-butanol layer was 
removed and the top of the resolving gel washed with distilled water. A 10ml 
stacking gel solution (5% (w/v) Protogel™ acrylamide, 0.13 M Tris-HCI, pH 6.5, 
0.1% (w/v) SDS) was polymerised with 3 mg ammonium persulphate (from a 
10% (w/v) solution) and 10 (xl of TEMED. The stacking gel was poured to the 
top of the mould, and a comb placed into the gel, and allowed to set for 1 hour 
at room temperature. The comb was then removed carefully, and the gel placed
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in an electrophoresis tank, which was filled with electrophoresis buffer (0.025 M 
Tris-HCI, pH 8.8, 0.096 M glycine, 0.1% (w/v) SDS). Bubbles were removed 
from the lower edge of the gel and unpolymerised acrylamide was washed from 
the wells of the stacking gel with electrophoresis buffer prior to loading of the 
protein samples.
Protein samples were prepared for electrophoresis by the addition of an 
equal volume of sample buffer(0.18M Tris -HCI, pH 6.5, 2% (w/v) SDS, 10% 
(w/v) glycerol, 2.6%(w/v) p-mercaptoethanol, 0.005% (w/v) bromophenol blue), 
and boiling for 3 min. Each protein sample was loaded onto the gel in a final 
volume of between 10 and 15(4,1. The gel was run at a constant current of 10 mA 
through the stacking gel and 20 mA through the resolving gel until the dye front 
was 0.5 cm from the lower edge of the gel. The gel was then removed from the 
electrophoresis tank and stained with 0.5% (w/v) Coomassie Brilliant Blue R in 
9:2:9 (v:v:v) methanol.acetic acid:water for 30 min and then destained overnight 
with 2:1:7 (v:v:v) methanol.acetic acid:water
2.3.6 Spectrophotometric assay for citrate synthase
Citrate synthase was assayed at 412nm in a Perkin Elmer Lambda Bio 
or Lambda 11 spectophotometer, using the method of Srere et al.(1963). The 
thiol group of the reaction product (free CoA) reacts with 5,5’-di-thiobis-2- 
nitrobenzoic acid (DTNB) to release thionitrobenzoate which absorbs at 412nm 
and has an absorption coefficient of 13,600 M'1 cm'1.
Coenzyme A was acetylated by dissolving 10 mg of coenzyme A in 1ml 
of Milli-Q water (on ice), and adding KHC03 to a concentration of 0.17M, and 
acetic anhydride to a concentration of 11mM. The solution was incubated on ice 
for 10 min to allow complete acetylation of the coenzyme A.
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Enzyme assays were performed at 55°C in a 1ml volume of 20mM 
EPPS, pH 8.0, 2mM EDTA containing 150pM Ac-CoA, 200(iM oxaloacetate and 
0.2mM DTNB. One unit of enzyme activity was defined as Ipmol CoA produced 
per min. Non-enzymic generation of CoA was measured by the omission of 
oxaloacetate from the assay. Note the EPPS buffer was made up to a pH of 
8.45 at 25°C, and the spectrophotometer water bath was set to 60°C (as the 
temperature of the reaction mix was found to decrease to 55°C after 1 min, the 
period of the assay).
2.4 Calculation of change in Gibbs free energy of activation of 
thermal inactivation.
The change in the AG of activation of thermal inactivation (AAGU*) 
between the wildtype PfCS, and a mutant PfCS, was calculated by using the 
following equation (Eyring, 1935):
A A G U — AGu. wt - AGu mut — R T  ln(ku.wt/ku.mut)
where AGU* wt is the free energy of activation of inactivation of the 
wildtype enzyme, AG^ mut is the free energy of activation of inactivation of the 
mutant enzyme, R is the gas constant, T is the temperature in Kelvin, and ku is 
the rate constant for inactivation.
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CHAPTER 3
Creation of Citrate Synthase Domain Swap Mutants
3.1 Introduction
Complementary to studying the role of specific residues in 
thermostability, the creation of chimaeric enzymes, in which large parts of the 
polypeptide chain are exchanged between homologous proteins, offers the 
possibility of investigating the role of larger substructures in conferring 
functionality and thermostability to a protein. Using this approach to investigate 
the structural basis of thermostability of CS from the archaea, it was decided to 
create CS chimaeric mutants by swapping the region coding for the small 
domain of PfCS, with that coding for the small domain of TpCS, and vice versa. 
This chapter describes the site directed mutagenesis carried out on PfCS and 
TpCS, to allow the region coding for the small domain to be cut out of each 
gene, and the subsequent ligation of the region coding for the TpCS small 
domain into the region coding for the PfCS large domain, creating the PYR::tp 
chimaeric CS. The ligation of the region coding for the PfCS small domain into 
the region coding for the TpCS large domain, creating the TP::pyr chimaeric CS, 
is then described. Both chimaeric CS mutants were further mutagenised by 
PCR to create restriction sites to allow their cloning into the expression vector 
pREC7-Nde1. The characterisation of both chimaeric CS’s, and PfCS and 
TpCS is then described.
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The reason for swapping the small domains between PfCS and TpCS 
was to determine whether the large domain (which contains the subunit 
interface and C terminus region), or the small domain (which makes up the 
active site, and is more flexible than the large domain) plays the dominant role in 
protein thermostability.
Several groups have used the strategy of making chimaeric enzymes 
between a mesophilic enzyme and its thermophilic counterpart to investigate the 
structural basis of thermostability. Numata et al. (1995) made chimaeric 3- 
isopropylmate dehydrogenases, by gene fusion between the enzymes from the 
mesophile Bacillus subtilis and the extremophile, Thermus thermophilus. The 
stability of each enzyme was approximately proportional to the content of the 
amino acid sequence from the T.thermophilus enzyme. The results suggested 
that amino acid residues contributing to thermostability distribute themselves, in 
general, evenly at least in the N-terminal half of the amino acid sequence of 
T.thermophilus isopropylamate dehydrogenase. Eidsness et al. (1997) made 
chimaeric enzymes by swapping p strand regions of rubredoxins (Rds) between 
P.furiosus and Clostridium difficile. The results from this study suggested that a 
global alignment, which optimised both main chain and side chain interactions 
between p-sheet strands and core residues, was more important than a few 
interactions within the p-sheet in conferring P.furiosus Rd-like thermostability. 
Singh & Hiyashi. (1995) made chimaeric p-glucosidases between Cellvibrio 
gilvus and Agrobacterium tumefaciens. The temperature optima for the 
chimaeras were found to be midway between that of both parents, and the C- 
terminal region of p-glucosidases was found to play an important role in 
determining enzyme characteristics.
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A number of research groups have produced chimaeric enzymes by 
swapping whole domains. Molgat et al. (1992) swapped the domains between 
E.coli CS and A.anitratum CS, and determined from these that the large 
domains are involved in subunit interactions while the small domains are 
involved in catalytic activity, and that it was the large domains which determined 
the chemical stability of the CS. Lebbink et al. (1995) swapped the domains of 
glutamate dehydrogenase from P.furiosus with Clostridium difficile. They found 
the effect of domain exchange on thermostability dramatic. Instead of the hybrid 
enzymes displaying a thermostability in between those of the parental enzymes, 
as found in the case of chemical stability, the hybrids were even less 
thermostable than C.difficile glutamate dehydrogenase
In PfCS and TpCS a single segment of DNA sequence codes for the 
small domain, flanked by segments coding for the large domain. Therefore, to 
swap both small domains, is a relatively simple manipulation.
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3.2 Methods
3.2.1 Site Directed Mutagenesis
The Altered sites 11® in vitro mutagenesis kit, supplied by Promega UK Ltd, was 
used for the site directed mutagenesis of TpCS and PfCS. The kit uses a vector 
called pAlter-1, which contains tetracycline and ampicillin resistance genes, 
however the ampicillin resistance gene has been inactivated by a frame shift 
mutation. To increase the frequency of mutants identified following the 
mutagenesis reactions, a mutagenic oligonucleotide supplied with the kit, which 
restores the ampicillin resistance gene, is used. Theoretically this 
oligonucleotide should bind to the single stranded DNA, at the same time as the 
oligonucleotide mutating the gene of interest. Thus, when the mutagenised 
vector DNA is plated out onto a plate containing ampicillin, the cells that grow 
should contain the desired mutation. Figure 3.1 shows the steps in the altered 
sites mutagenesis procedure. The first step in the procedure was to clone the 
TpCS and PfCS genes to be mutagenised into the pAlter-1 vector. After this the 
kit manufacturer’s instructions, supplied with the kit, were followed with some 
modifications. Firstly, single stranded template DNA was prepared by the M13 
infection method because of problems with mutating denatured double-stranded 
DNA. Secondly due to problems encountered trying to transform into the E.coli 
strain ES1301, another repair strain of E.coli, DHa , was used. These cells 
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Figure 3.1 The altered sites®ll in vitro mutagenesis procedure.
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3.2.2 Transfer of proteins for N-terminal sequencing
Following SDS-PAGE (section 2.3.4) the acrylamide gel was equilibrated 
in transfer buffer pH 8.3, 50mM Tris, 50mM glycine, 20% (v/v) methanol, for 30 
min. Twelve pieces of Whatman 3MM paper, and one piece of PVDF 
membrane (Immobilon), were cut to the same size as the gel, and were 
equilibrated in transfer buffer for 15 min. Six pieces of the wetted Whatman 
3MM paper were placed on the anode plate of the electroblotter, the PVDF 
membrane was placed on top of this stack, and the SDS-PAGE gel on top of the 
PVDF membrane, and finally six pieces of Whatman 3MM paper were placed on 
top of the gel. The gel was electroblotted at 50mA for 3 hours, the membrane 
was then stained in 0.1% (w/v) Coomassie brilliant R, 50% (v/v) methanol, 7% 
(v/v) acetic acid for 2 min and destained in 50% (v/v) methanol, 7% (v/v) acetic 
acid for 1 hour. Finally the membrane was dried in an oven at 40°C for 1 hour 
and the protein band of interest cut out of the membrane.
Protein samples were sent for N-terminal sequencing to Zeneca 
Pharmaceuticals , Mereside, Alderley Park, Macclesfield, Cheshire, SK104TG.
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3.3 Results
3.3.1 Design of chimaeric domain swap mutants
The GCG programme was used to search for unique enzyme restriction 
sites flanking the regions coding for the small domain of PfCS and TpCS. To 
cut out the DNA region coding for the small domain from that coding for the 
large domain in the TpCS and PfCS genes, the restriction sites Apa1 and BspE1 
were selected. These sites were chosen as the Apa1 site occurred naturally 
once in the PfCS gene, and allowed a cut to be made in the region coding for 
the loop region between helix M and helix N, and the BspE1 site occurred 
naturally once in the TpCS gene, and allowed a cut to be made in the region 
coding for the end of helix R. To allow the region coding for the small domains 
to be cut out and swapped it was necessary to create an Apa1 site in TpCS (at 
the same position as it is found in PfCS), and a BspE1 site in PfCS (at the same 
position as it is found in TpCS), see Fig 3.2.
C
T.acidophilum Cs TGCGGCCCTCAAGGGTCCGCTGCATGG 
P.furiosus CS AGGAGCTTTAAAGGGCCCAATCCATGG
natural Apa1 site




Figure 3.2 The DNA sequence adjacent to the Apa1 and BspE1 sites in 
PfCS and TpCS, and the base changes necessary to create an Apalsite 




An amino acid alignment between PfCS, and TpCS is shown in Fig 3.3. 
The region shown in italic represents the small domain, the arrows indicate the 
positions where the small domains were swapped, using the restriction enzymes 
Apa1 and BspE1.
3.4 Site Directed Mutagenesis
The Altered Sites® II in vitro mutagenesis kit was used to create the 
Apa1 and BspE1 sites in TpCS and PfCS, respectively. The first step in the 
altered sites procedure was to clone the TpCS and PfCS genes into the pAlter-1 
vector.
3.4.1 Cloning of the P.furiosus CS gene into pALTER-1
The PfCS gene was present in a pKK223-3 vector (pBAP3103) into which it had 
been cloned as an EcoR1-Hindlll fragment (Muir et al., 1995). It was decided to 
use EcoR1 and Hindlll restriction enzymes to cut the gene out of the pKK223-3 
vector, and clone the EcoR1-Hindlll fragment into the pAlter-1 vector.
Approximately 10 ng of pKK223-3 PfCS vector (pBap3103) was digested 
with EcoR1 and Hindlll and the products were separated on a 1% (w/v) agarose 
gel. A band of approximately 1200bp was excised from the gel and purified 
using the Gene Clean method. Approximately 5|ig of p-Alter-1 DNA was also 
digested with EcoR1 and Hindlll, and the products were separated on a 1% 
(w/v) agarose gel. A band of 5.7kb in size was excised from the gel and purified 
using the Gene Clean method. The PfCS gene was then ligated into the pAlter- 
1 vector, and transformed into JM109 cells, which were plated out onto LB 
plates containing 0.5mM IPTG, 12.5 \ig tetracycline/ml and 40 |tig X-Gal/ml.
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Figure 3.3 Amino acid alignment between PfCS, and TpCS. The sequence 
shown in italic represents the small domain, and the arrows indicate the 
positions where the small domains were swapped, using the restriction enzymes 
Apa1, and BspE1
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White colonies were picked, restreaked and grown up overnight for the 
purpose of preparing ‘miniprep’ DNA (see section 2.2.1). The DNA from each 
clone was digested with EcoR1 and Hindlll, and the digests run on a 1% (w/v) 
agarose gel. One clone could be seen to contain an EcoR1-Hindlll band of 
approximately 1200bp; this pALTER-1 vector containing the PfCS insert was 
designated pBAP3104.
3.4.2 Cloning of the T.acidophilum CS gene into pALTER-1
The TpCS gene was present in a pUC19 vector (pCSEH), into which it 
had been cloned as an SpH1-EcoR1 fragment (Sutherland et al., 1990). The 
EcoR1 site was at the 3’ end of the TpCS gene, as opposed to the 5’ end of the 
gene in the case of the PfCS construct (pBAP3103), and therefore the TpCS 
gene had to be cloned into the pAlter-1 vector in the opposite orientation to the 
PfCS gene.
Approximately 10 pg of pCSEH DNA was digested with SpH1 and 
EcoR1 and separated on a 1% (w/v) agarose gel. A band of approximately 
1300bp was excised from the gel and purified using the Gene Clean method. 
Approximately 5|ig of pAlter-1 DNA was also digested with Sph1 and EcoR1, 
and separated on a 1% (w/v) agarose gel. A band of 5.7 kb in size was excised 
from the gel and purified using the Gene Clean method. The TpCS gene was 
then ligated into the pAlter-1 vector, and transformed into JM109 cells, which 
were plated out onto LB plates containing 0.5mM IPTG, 12.5 ^g/ml tetracycline 
and 40 i^g X-Gal/ml. White colonies were picked, restreaked and grown up 
overnight for the purpose of preparing ‘miniprep’ DNA (see section 2.2.1). The 
DNA from each clone was digested with Sph1 and EcoR1 enzymes, and the
digests were run on a 1% (w/v) agarose gel. Clone 7 contained a EcoR1-SpH1
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fragment corresponding to 1300bp, and this pALTER-1 vector clone containing 
the TpCS insert was designated pBAP3004.
3.4.3 Mutagenesis Reactions
Two mutagenic oligonucleotides were designed to create the required 
restriction sites (see Fig 3.4): MAA-1, a 29 base pair oligonucleotide designed to 
create an Apa1 site in TpCS, and MAA-2, a 30 base pair oligonucleotide 
designed to create a BspE1 site in PfOS. The restriction sites are highlighted in 
bold.
MAA-1 5’ CGCCGGGAGTTCCCGGGCGACGTACCGCC 3’
MAA-2 5' GTTGACTACTGGTCCGGATTAGTTTTCTAT 3’
Figure 3.4. Primers designed to introduce an Apa1 site into TpCS, and a
BspE1 site into P/CS.
Both oligonucleotides were supplied by R&D Systems Ltd in an 
unphosphorylated form, and thus they had to be phosphorylated before being 
used in the mutagenesis reactions. The phosphorylation and mutagenesis 
reactions were carried out as detailed in the kit manufacturer’s instructions. 
Following the mutagenesis reactions, transformation into E.coli strain DH5a, and 
transformation into into E.coli strain JM109, colonies were picked and used to 
prepare ‘minipreps’ of DNA. The TpCS mutated to introduce an Apa1 site was 
designated pBAP3005, while the P/CS mutated to introduce a BspE1 site was 
designated pBAP3105. When clones 3005 and 3105 were singly digested with 
Apa1 and BspE1, respectively, a single band was obtained, showing that the 
Apa1 and BspE1 restriction sites had been created (gel not shown).
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3.4.4 Exchange of the regions coding for the small domains within 
pALTER-1
The previous section described the creation of restriction sites to allow 
the small domains to be swapped. This section describes how the regions 
coding for the small domains were cut out and swapped between TpCS and 
P/CS.
Large scale restriction digests of clones pBAP3005 and pBAP3105 were 
set up with the enzymes Apa1 and BspE1. These enzymes use incompatible 
restriction enzyme buffers and digestion temperatures, so the clones were first 
digested with Apa1, the DNA was precipitated, redissolved in water, digested 
with BspE1, and separated on a 1% (w/v) agarose gel (Fig 3.5). The Apa1- 
BspE1 300bp and 6.8kb fragments were cut out and gel purified using the Gene 
Clean method.
Overnight ligations were set up with the P/CS 300bp Apa1-BspE1 
fragment and the TpCS 6.8kb Apa1-BspE1 fragment, and the TpCS 300bp 
Apa1-BspE1 fragment with the P/CS 6.8kb Apa1-BspE1 fragment. The ligations 
were transformed into JM109 cells, which were plated out onto LB plates 
containing ampicillin at 100fig/ml. White colonies were picked from these 
plates, restreaked and grown up overnight for the purpose of preparing 
‘miniprep’ DNA (see section 2.2.1). A diagrammatic representation of the Apa1- 
BspE1 restriction digestion of pBAP3005 and 3105, and swapping of the small 
domains is shown in Fig 3.6
‘Minipreps’ from cells transformed with the TpCS large domain / P/CS 
small domain ligation, and with the P/CS large domain / TpCS small domain
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1 2 3 4 5 6  7 8 9
6.8kb
300bp
Figure 3.5: Restriction digestion of pBAP3005 and pBAP3105 clones 
with Apa1, BspE1, and Hindlll restriction enzymes. 1) 1 kilobase 
ladder DNA. 2) pBAP3005 digested with Apa1. 3) pBAP3105 digested 
with Apa1. 4) pBAP3005 digested with Hindlll. 5) pBAP3105 digested 
with Hindlll. 6) Uncut pBAP3005. 7) Large scale digest of pBAP3005 
with Apa1 and BspE1. 8) Uncut pBAP3105. 9) Large scale digest of 
pBAP3105 with Apa1 and BspE1.
ligation, were digested with Hindlll restriction enzyme to identify the domain 
swapped mutants. Hindlll enzyme was used as wildtype TpCS has one Hindlll 
site which is located in the small domain, and pAlter-1 also contains a Hindlll 
site; thus the movement of the TpCS can be followed by digestion with Hindlll, 
(see Fig 3.7). A photograph of the gel of a Hindlll digest of pBAP3005, 








TP::pyr CS (pBAP3006) PYR::tp CS (pBAP3106)
* Site created by site directed mutagenesis
Figure 3.6 Diagrammatic representation of the restriction digestion of 
TpCS and P/CS with Apa1 and BspE1, to cut out the regions coding for 
the small domains, (whole genes are in one colour) and swap them to 
























Figure 3.7 Diagram showing the position of the Hindlll sites in the CS’s. 
Hindlll* represents the Hindlll site within the TpCS small domain.
5 4 3 2 1
m  mm
Figure 3.8 Hindlll digestion of 4CS’s within the pAlter-1 vector. 1)1 kb ladder. 
2) pBAP3105. 3) pBAP3005. 4) PYR::tp (pBAP3106). 5) TP::pyr (pBAP3006).
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From Fig 3.8 it can be seen that TpCS within pAlter-1 (pBAP3005) 
digested with Hindlll gave bands of approximately 6kb and 1kb, Hindlll digestion 
of P/CS in pAlter-1 (pBAP3105) gave one band of 7kb, while a TpCS large 
domain/P/CS small domain construct gave one Hindlll fragment of 7kb, since 
this construct will have lost a Hindlll site. On the other hand, the Hindlll digest 
of the P/CS large domain/TpCS small domain construct gave a small 260 bp 
fragment since it had gained an extra Hindlll site and the P/CS gene was cloned 
into pAlter in the opposite orientation direction to TpCS. This was proof that two 
clones had been created where the small domains had been swapped. The 
TpCS large/P/CS small domain construct (TP::pyr) within pAlter-1 vector was 
designated pBAP3006. The P/CS large domain/TpCS small domain construct 
(PYR::th) within the Alter-1 vector was designated pBAP3106.
3.4.5 Sequencing of pBAP 3006 and pBAP 3106 CS mutants
To determine whether any additional mutations had been created at the 
domain boundary regions in the domain swap mutants pBAP3006 and 
pBAP3106, a series of sequencing reactions were carried out. A number of 
oligonucleotide primers were designed to sequence across the boundary 
regions between the large and small domains (full details of the sequencing 
primers used are given in Appendix A).
Fig 3.9 shows the binding positions of the sequencing primers used to 
sequence clones pBAP3006, and pBAP3106. Primer MAA-3 binds 65bp 
upstream of the introduced Apa1 site in pBAP3006, primer MAA-6 binds 65bp 
upstream of the BspE1 site in pBAP3006, primer MAA-5 binds 65bp upstream of 









Figure 3.9. Positions at which sequencing primers bind on clones 
pBAP3006 and pBAP3106.
introduced BspE1 site of pBAP3106. Sequencing of clone pBAP3006 with 
MAA-3 and MAA-4 primers confirmed that the P/CS small domain had been 
successfully cloned into the TpCS large domain. The small domain was 
completely sequenced as were the inter-domain boundary regions; no other 
mutations were found.
Sequencing of clone pBAP3106 with primers MAA-5 and MAA-6 
confirmed that the region coding for the small domain of TpCS had been cloned 
into the P/CS large domain. From the sequence obtained around the inter­
domain boundary region no other mutations were found.
Apa1 BspEI
MAA-5




3.5 Expression of Domain Swapped Mutants
Having produced the domain-swapped CS mutants, the next objective 
was to express the chimaeric CS's, in order to obtain sufficient quantities of 
protein for characterisation of the mutants. To achieve this it was initially 
decided to clone the TP::pyr CS into pUC19, and PYR::tp CS into pKK223-3, as 
these were the vectors used previously for the expression of TpCS and P/CS. 
However later a decision was made to clone both the TP::pyr CS and PYR::tp 
CS into a pREC7-Nde1 vector, because this vector gives much higher levels of 
expression of protein than pUC19 or pKK223-3.
3.5.1 Cloning of PYR::tp chimaeric citrate synthase into pRec7-Nde1
To clone PYR::tp CS into pRec7-Nde1 it was necessary to replace the 
EcoR1 site with a Nde1 site at the 5’ end of the gene in order to use the start 
codon from the pRec7-Nde1 vector. At the same time It was decided to replace 
the 3’ Hindlll site with a Kpn1 site, to facilitate the cloning of the PYR::tp CS 
gene by eliminating the need to perform partial Hindlll digests (because PYR::tp 
CS {pBAP3106} contained two Hindlll sites).
The oligonucleotides shown in Fig 3.10 were designed to add an Nde1 
site and a Kpn1 site to the 5’ and 3’ ends, respectively, of PYR::th CS by PCR.
5’ GG G A ATT CC ATAT G AATACG G A AAA ATACCTTGCT MAA-7 (Nde1)
5’ CGGGGTACCAATGCTCATTTTATCTACCTCC MAA-8 (Kpn1)
Figure 3.10 Oligonucleotides designed to add an Nde1 and a Kpn1 site to Pyr::tp 
CS. The DNA sequences in bold represent the Nde1 and Kpn1 restriction sites.
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The conditions used in the PCR were:
0.5(xg of pBAP3106 DNA (PYR::th cloned into p-Alter-1)
18 pmoles of each primer, except where stated.
The concentration of magnesium chloride in each reaction was varied, from 1- 
5mM. The other PCR conditions are given in section 2.2.11
Following the PCR amplification, 10pl of each reaction was run on a 1% 
agarose gel to check whether the PCR had been successful (Fig 3.11). It can 
be seen that the PCR fragments produced were approximately 1300bp, which is 
the size of PYR::tp CS gene.
1 2 3 4 5 6 7
1300bp
Figure 3.11 PCR products from the amplification of pBAP3106 to add 
Nde1 and Kpn1 sites to PYR::tp CS. 1) kb ladder DNA. 2) Lanes 2-6 
varying concentrations of magnesium chloride from 1-5mM. 7) 2mM
magnesium sulphate, 60 pmoles of each primer.
The products from the PCR reactions containing 1 to 5 mM magnesium 
sulphate, and 60 pmoles of each primer were pooled and purified by the ethanol 
precipitation method (see section 2.2.3). Restriction digestion of the purified
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PCR product and the pRec7-Nde1 vector took place overnight at 37°C. The 
digests were run on a 1% (w/v) agarose minigel, and the pRrec7-Nde1 and 
PYR::tp Nde1-Kpn1 bands were cut out of the gel and purified using the Gene 
Clean method. A ligation was set up using ligase supplied by Boehringer 
Mannheim and left for 1 hour at room temperature, and 1 hour at 37°C, before 
being transformed into the CS-minus strain MOB154 (see sections, 2.2.7, and 
2.2.8). The transformants were grown overnight at 37°C on LB plates 
containing ampicillin at a concentration of 125^ig/ml; eight colonies were 
selected, and ‘miniprep’ DNA was prepared from these for the purpose of 
restriction digestion. The ‘miniprep’ samples were digested with both Kpn1 and 
Nde1 and the digests run on a 1% (w/v) agarose gel). The results of this gel 
were inconclusive so ‘maxiprep’ DNA was prepared from some of the clones. 
When DNA from the ‘maxiprep’ was digested with Kpn1 a band of 3.8 kb could 
be seen. Since the pRec7-Nde1 vector is 2.5 kb this showed that the pRec7- 
Nde1 vector contained a 1.3 kb insert. When this DNA was digested with Nde1 
and Kpn1 a band of 1300bp could clearly be seen. This corresponded to the 
CS gene (see Fig 3.12). From this gel it was concluded that the PYR::tp CS had 
been cloned into the pRec7-Nde1 vector. This clone was designated 
PBAP3110.
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Figure 3.12 Nde1, Kpn1 digest of pBAP3110 construct. 1) 1kb ladder, 
2) Kpn1 only, 3) Kpn1 and Nde1 digest of construct, 4) uncut DNA.
3.5.2 Cloning of the wildtype P/CS into the pRec7-Nde1 vector.
To clone P/CS into pRec7-Nde1 as an Nde1-Kpn1 fragment, the same 
PCR strategy (primers and conditions) was used as for the cloning of PYR::tp 
CS into pRec7-Nde1 (section 3.5.1).. The overall cloning procedure was also 
very similar in terms of the purification of PCR product, digestion of product with 
Nde1 and Kpn1, and ligation into pRec7-Nde1. pRec7-Nde1 vectors containing 
P/CS were identified by restriction digestion with Kpn1 and Nde1. The pRec7- 
Nde1 construct containing P/CS was designated pBAP3031.
3.5.3 DNA Sequencing of pBap 3110, and pBap 3031
Having cloned the PCR amplified PYR::tp CS and P/CS into the pRec7- 
Nde vector, it was important to establish whether any sequence errors had been 
introduced during the PCR process and subsequent cloning.
A number of primers were designed to obtain the full DNA sequence of
these clones. The DNA sequences of these primers are given in Appendix A. 
MAA-9 was designed to bind 20 bp upstream of the Nde1 site (on the sense 
strand) of pRec7-Nde1, to allow read through from the 5’ end of inserts cloned 
into the Nde1 site of pRec7-Nde1. MAA-10 was designed to bind 20 bp 
downstream from the Kpn1 site (on the antisense strand of the pRec7-Nde1 
vector), so as to allow read through from the 3’ end of inserts cloned into the 
Kpn1 site. MAA-11 was designed to bind to DNA adjacent to base number 440 
of the sense strand of P/CS to allow the complete sequencing of P/CS related 
inserts.
0.5pg of pBAP3110 and pBAP3031 ‘maxiprep’ DNA was used in each 
sequencing reaction along with the above primers. Sequencing was carried out 
using the ABI automated sequencer (see section 2.2.12). All of the pBAP3110, 
and pBAP3031 constructs were sequenced and the sequence obtained was that 
expected for P/CS and the PYR::tp CS chimaera.
3.5.4 Cloning of TP::pyr CS into pUC19
A large scale EcoR1/SpH1 double digest was set up of the vector 
pUC19 and the TP::pyr CS construct (pBAP3006). The 1300bp CS EcoR1- 
SpH1 fragment and the double digested pUC19 vector DNA were gel purified 
using the Gene Clean method, and the purified 1300bp TP::pyr CS EcoR1- 
SpH1 fragment was ligated into the purified digested vector. Transformants 
were analysed by restriction digestion with EcoR1 and Sph1; positive clones 
gave 1300bp and 2.7kb fragments with these enzymes. The TP::pyr CS 
construct cloned into pUC19 as an Sph1-EcoR1 fragment was designated 
pBAP3007, Fig 3.13 shows a photograph of a gel of the EcoR1-Sph1 digest of 
pBAP3007.
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1 2 3 4 6
Figure 3.13 EcoR1/Sph1 digest of pBAP3007 construct. 1 and 6) 1 
Kilobase ladder DNA. 2) Uncut pBAP3007. 3 and 4) EcoR1-Sph1
digested pBAP3007.
The 1.3kb TP::pyr CS gene and the 4kb single cut pBAP3007 construct 
bands can be clearly seen, while the 2.7kb band corresponding to pUC19 is 
weakly visible in Fig 3.15.
3.5.5 Cloning of the TP::pyr CS into the pRec7-Nde vector
The aim of this experiment was to put the TP::pyr CS into a vector that 
would give a good level of protein expression. The oligonucleotides MAA-12 
and MAA-13 were designed to add an Nde1 site onto the 5’end of TP::pyr CS, 
and a Kpn1 site to the 3’ end of TP::pyr CS, to allow TP::pyr CS to be cloned 
into the pRec7-Nde vector (Fig 3.14)
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MAA-12 5’ TGTAGAGGTGTAC ATATGCCAG A AACT G 3’sense primer
MAA-13 5’ TGCAGCCCGGGGGTACCGGATCCGAAAACAC 3’ antisense primer
Figure 3.14 Oligonucleotides designed to add an Nde1 and a Kpn1 site
to TP::pyr CS. The Nde1 and Kpn1 sites are shown in bold.
The template DNA used for each reaction was 0.5^ig of pBAP3007 
(TP::pyr CS in pUC19), 18pmoles of each primer were used, the concentration 
of MgCI2 was 5mM. For the other PCR conditions see section 2.2.11.
Products of the PCR reaction were pooled together and the DNA was 
ethanol precipitated (see section 2.2.3), before being digested overnight at 37°C 
with Nde1 and Kpn1. The pRec7-Nde1 vector was also digested with Kpn1 and 
Nde1. Both the digested vector and the PCR products were run on a 1%(w/v) 
agarose minigel, and the Nde1-Kpn1 fragments were purified using the Gene 
Clean method. The insert and vector DNA were ligated together at room 
temperature for 1 hour, and then at 37°C for 1 hour, before being transformed 
into the CS-minus E.coli strain MOB154 and plated out onto LB plates 
containing ampicillin at a concentration of 125pg/ml. The plates were incubated 
at 37°C overnight and the next day colonies were picked, restreaked and grown 
up overnight for the preparation of DNA. DNA was prepared by the ‘miniprep’ 
method, and was digested with Nde1; the digests were run on a 1% (w/v) 
agarose gel, (Fig 3.15). Seven clones were screened to select one with the 
appropriate insert. From Fig 3.15 it could be seen that lanes 3, 5, and 7 
corresponded to clones where the TP::pyr CS gene had been successfully 
cloned into the pRec7-Nde1 vector, whilst lanes 2, 6, and 8 corresponded to
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vector only. The TP::pyr CS gene cloned into pRec7-Nde1 construct was 
designated pBAP3008.
1 2 3 4 5 6 7 8
4.0 kb------->
2.7 kb------->
Figure 3.15 Nde1 digest of TP::pyr CS in pRec7-Nde1 recombinants. 1) 
1 kilobase ladder. 2-8) Clones 1-7
3.5.6 DNA sequencing of TP::pyr in pUC19 (pBAP3007) and in pRec7- 
Nde1 (pBAP3008)
To determine whether any sequence errors had been introduced into 
pBAP3007 by the mutagenesis reaction and subsequent cloning into pUC19, or 
into pBAP3008 by the PCR reaction, a number of primers were used to enable 
all of the DNA sequence of pBAP3007 and pBAP3008 to be determined. These 
primers were MAA-3, MAA-6, MAA-9, MAA-10, and MAA-14. Full details of the 
primers designed for sequencing are shown in Appendix A, and the binding 
position of the sequencing primers within the TP::pyr CS mutants are shown in 
Fig 3.9. MAA-3 binds 65bp upstream of the TpCS Apa1 site, MAA-6 binds 65bp 
upstream of the P/CS bspE1 site, MAA-14 binds 30bp downstream of the 
EcoR1 site to the antisense strand of the pUC19 vector (allowing read through
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of inserts cloned into the EcoR1 site), MAA-9 was designed to bind 20bp 
upstream of the sense strand of pRec7-Nde1, to allow read through from the 5’ 
end of inserts cloned into the Nde1 site of pRec7-Nde1. MAA-10 was designed 
to bind 20bp downstream from the Kpn1 site on the antisense strand of the 
pRec7-Nde1 vector, so as to allow read through from the 3’ end of inserts 
cloned into the Kpn1 site,
Three pmoles of each primer and 0.5pg of pBAP3007 and pBAP3008 
‘maxiprep’ DNA were sent away for sequencing. The sequence obtained 
showed that the sequence of both clones was as expected with no other 
mutations observed throughout the entire sequence.
3.5.7 N-terminal sequencing of PYR::th CS (pBAP3110) and TP::pyr 
CS (pBAP3007) mutant proteins
While the DNA sequence had been verified for both mutant constructs, it 
was not known whether the proteins would be expressed using the correct start 
codon, whether the N-terminal amino acid sequences of the expressed proteins 
would have the methionine residue cleaved or not, or if any other N-terminal 
cleavage of the proteins would occur. To answer these questions, large scale 
cultures (1 litre of LB containing ampicillin at a concentration of 125p,g/ml, in 2 
litre conical flasks) of pBAP3007 and pBAP3110 were grown in a 37°C incubator 
for 48 hours. The cells were spun down and the CS’s purified on a Matrex Red 
Gel A column (see methods sections 2.3.2, 2.3.3, and 2.3.4). Samples of both 
proteins were loaded and run on 10% SDS polyacrylamide gels (see methods 
section 2.3.5), which were then electroblotted for 2 hours at 50 mAmps to 
transfer the separated proteins on to nitrocellulose membranes (see section
3.2.2). These membranes were stained and destained as in section 3.2.2., the 
protein bands were cut out and sent for sequencing.
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The amino acid sequences obtained are shown below beside the 
published N terminal sequences of Pf CS, and TpCS.
Published To CS Met Pro Glu Thr Glu Glu lie Ser Lys 
TP::pyr(BAP3007) Pro Glu Thr Glu Glu lie Ser Lys
Published Pf CS Met Asp Thr Glu Lys Tyr Leu Ala Lys Gly
PYR::tp (BAP3110) Met Asp Thr Glu Lys Tyr Leu Ala Lys Gly
The amino acid sequence showed that the CS produced from the
TP::pyr construct had the N-terminal methionine cleaved, while the PYR::th CS 
did not . The amino acid sequences obtained corresponded to the expected 
sequences, and no N-terminal cleavage of the proteins occurred. Both domain 
swapped CS mutants have now been confirmed by restriction digestion, DNA, 
and N terminal protein sequencing.
3.6 Purification of CS Enzymes
Large scale cultures of the domain swap mutants, and of the wild type 
enzymes TpCS and P/CS, were set up for expression of the CS’s (see section
2.3.2). The innate thermostability of the CS enzymes from P.furiosus and 
T.acidophilum permitted a heat step to be used as a preliminary purification 
step. Previous experiments showed that heating at 80°C for 15 min was 
suitable as a preliminary purification step for P/CS (Muir et al., 1995), and 
heating at 65°C for 15 min was suitable as a preliminary purification step for 
TpCS (James et al., 1994). Preliminary denaturation experiments with the two 
domain swap CS mutants showed that the PYR::tp CS construct (pBAP3110), 
could be partially purified using a heat step of 80°C for 15min, and the TP::pyr 
CS construct (pBAP3008) could be partially purified using a heat step of 60°C
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for 15 min.
Following the heat step, the CS’s were purified by Matrex Red gel A 
chromatography (see section 2.3.4). Protein determination was carried out 
using the Bradford method (section 2.3.1). Figs 3.16 and 3.17 shows some of 
the SDS-PAGE gels run during the purification of the mutant and wildtype CS’s, 
and Table 3.1 shows the yield and specific activity for each step of the 
purification.
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Figure 3.16 SDS-PAGE analysis of fractions from the purification of 
TpCS and TP::pyr CS. 1) Low range molecular markers. 2) Cell free 
extract. 3) Heat treated supernatant. 4) Red gel A unbound fraction. 5-7) 
Red gel A eluted fractions.
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PYR::tp CS purification
1 2 3 4 5 6 7
45kDa
* —  43 kDa
P/CS purification
Figure 3.17 SDS-PAGE analysis of fractions from the purification of 
P/CS, and PYR::tp CS. 1) Low range molecular markers. 2) Cell free 
extract. 3) Heat treated supernatant. 4) Red gel A unbound fraction. 5-7) 
Red gel A eluted fractions
Table 3.1 Purification of wildtype TpCS and P/CS and domain 
swapped mutants. ‘ Indicates that the specific activity figures are low 

























5.0 188 940 55.2 276 100 3.4
Heat step 3.5 164 574 17.8 61 62 9.4
Matrex 
red gel A




10 11.3 113 41 410 100 0.3*
Heat step 7 10.6 74 5 34.7 65.6 2.1 *
Matrex 
red gel A




8 28 222 43 344 100 0.6
Heat step 5.5 27 149 14 78 67 1.9
Matrex 
red gel A




8 44 351 49 390 100 0.9
Heat step 6 37 225 12.4 74.4 64 3
Matrex 
red gel A
4 31 123 2.8 11.1 35 11
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3.7 Characterisation of the purified CS enzymes
3.7.1 Determination of the kinetic parameters of the CS’s
To determine values of Km and Vmax for an enzyme that uses two 
substrates, one should ideally do a ‘5x5 matrix’ of substrate concentrations 
experiment (Henderson, 1992). However a ‘5x5’ could not be carried out in the 
case of these four CS’s because their Km values were so low that when both 
substrates were at a low concentration the rates of reaction could not be 
accurately measured by the spectrophotometer. Instead the concentration of 
one substrate was held in excess while the concentration of the second 
substrate was altered, and vice versa. The high concentrations of substrates 
used were 150^M and 200p,M of Ac-CoA and OAA respectively unless stated 
otherwise.
Dilutions of each of the four CS’s were carried out in 50mM phosphate 
pH7.2, 2mM EDTA to determine an appropriate enzyme concentration, that 
would produce a measurable rate on the spectrophotometer, but that did not 
use up all the substrate too quickly at low substrate concentrations. The CS’s 
were assayed in 20mM EPPS pH 8.0, 2mM EDTA, 100mM KCI, at 55°C. Each 
CS was assayed 3 times and the direct linear plot of Eisenthal and Cornish- 
Bowden (1974) was used to determine the Km and Vmax values, except in the 
case of the TP::pyr CS construct which was substrate inhibited by Ac-CoA. In 
this case, Km and Vmax values for the substrate Ac-CoA were determined using 
the Scientist plot to fit the rates to a curve given by the equation:
  Vmax______
1+Km + _ S _
S Ki
The inhibitor constant (Ki) determined for the substrate Ac-CoA from the
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Scientist plot was 61 (±24). The Km and Vmax determination for the substrate 
oxaloacetate for TP::pyr CS was carried out at an Ac-CoA concentration of 5pM, 
as this was the concentration of Ac-CoA which gave the highest rate. Mean Km 
and specific activity values (± standard errors), and turnover numbers/monomer, 
measured at 55°C for the four CS’s are shown in Table 3.2. Note the specific 
activity quoted for the TP::pyr CS construct is determined using the mean V max 
values calculated for the substrate Ac-CoA.
Citrate
Synthase








P.furiosus 10 ± 1.3 3.0 ±0.7 17 ±2 12
T.acidophilum 2 ±0.2 4.8 ±0.5 68 ± 4 49
PYR::tp 11 ±0.5 8.4 ±1.0 30 ±1 22
TP::pyr 2.7± 1.0 1.7 ±0.3  * 13 ± 2 9
Table 3.2 Comparison of turnover numbers, Km values for the 
substrates oxaloacetate and Ac-CoA, and the specific activities of the four CS’s 
at 55°C. * Indicates that this enzyme is substrate inhibited by Ac-CoA.
V against S plots of the data used to determine the Km and Vmax values 
of TP::pyr CS and PYR::tp CS were drawn using the Microcal Origin graphics 
package (Fig 3.18a-d). A simulated line was plotted through the experimentally 
determined V versus S points using simulated V and S values calculated from 
the equation;
y  _ Vmax S 
S + Km
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using the determined Km and Vmax values. Where substrate inhibition was 
occurring the simulated V and S values were determined from the substrate 
inhibition equation;
_  Vmax______
1+Km + _ S _
S Ki
using the determined Km, K, and Vmax values. Note each plot was produced 
from the data from one Km and Vmax determination for each enzyme with the 
substrates oxaloacetate and Ac-CoA. These plots show in the case of figs 
3.18a, 3.18b, and 3.18c that the data fit a Michaelis-Menton kinetic model. 
Whereas in the V against S plot in Fig 3.18d it can be seen that TP::pyr CS is 
not obeying Michaelis-Menton kinetics with respect to Ac-Coa, rather it is 
showing a substrate inhibition effect.
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Data: PYR::tp OAA 
Model: Michaelis-Menten 
Vm 0.0079 (± 0.00005) pmol/min
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Figure 3.18a V against S plot of the data used to determine the Km and 




Data: PYR:dp Ac-CoA 
Model: Michaelis-Menten 
Vm 0.0085 (± 0.0002) pmol/min
Km 8.0 (±0.6) pM
0.004 -




0 5 10 15 20 25 30
[acetyl-CoA] (pM)
Figure 3.18b V against S plot of the data used to determine the Km and 
Vmax values for PYR::tp CS for the substrate Ac-CoA.
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Vm 0.0027 (±0.0001) pmol/min
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[oxaloacetate] (nM)
Figure 3.18c V against S plot of the data used to determine the Km and 
Vmax values for TP::pyr CS for the substrate oxaloacetate.
0.0020 - Data: TP::pyr AcCoA 
Model: Substrate inhibition 
Km 1.7(± 0.9) pM
Ki 53 (± 21) pM
Vm 0.0028 (± 0.0006) pmol/min0.0015




0.0000 -l h 
0 20 40 60 80 100 120 140 160 180
[acetyl-CoA] (pM)
Figure 3.18d V against S plot of the data used to determine the Km and 
Vmax values for TP::pyr CS for the substrate acetyl-CoA.
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3.7.2 Thermal stability of the four CS’s
The aim of this set of experiments was to compare the mutant CS 
enzymes PYRr.tp and TPr.pyr, with PfCS and TpCS in terms of their abilities to 
withstand thermal denaturation.
All thermal stability studies were carried out in the presence of 50mM 
phosphate pH 7.2, 2 mM EDTA using an enzyme concentration of 0.1 mg/ml. 
The buffer was heated to the required temperature in an Eppendorf tube in a 
heating block, and the temperature inside a second Eppendorf containing buffer 
only was measured using an electronic temperature probe. When the desired 
buffer temperature was reached in the control tube, enzyme was added to the 
first Eppendorf tube, mixed and the timer started. Aliquots were removed at 
timed intervals and placed into thin walled glass tubes on ice, where they were 
stored prior to assay. A time zero value was obtained by assaying an 0.1 mg/ml 
concentration of enzyme in the same buffer kept at 4°C. Samples were 
assayed in triplicate.
It was difficult to choose a single temperature at which to compare the 
thermal inactivation of all four enzymes, since preliminary experiments showed 
that the thermostabilities of the four enzymes varied widely. However, a 
temperature of 85°C was initially chosen to compare the thermal stabilities of the 
4 CS’s. A graph showing the relative thermal stability of the four CS’s at this 
temperature is shown in Fig 3.19. From this graph it can be seen that the 
TP::pyr CS was rapidly inactivated at 85°C, and that PfCS and PYR::tp CS were 
not inactivated at this temperature. For this reason the inactivation of PYR::tp 
and PfCS was followed at a higher temperature of 95°C (note TpCS was
inactivated very rapidly at 95°C). Fig 3.20 shows the relative thermostability of
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PfCS and PYRr.tp CS at 95°C. The inactivation rate constants calculated for the 









TP::pyr 85°C 0.28± 0.004
T.acidophilum 85°C 0.048± 0.002
PYR::tp 95°C 0.12±0.004
P.furiosus 95°C No detectable 
inactivation
Table 3.3 Inactivation rate constants for the chimaeric and wildtype CS’s 
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Figure 3.19. Relative thermostability of PfCS, TpCS, and the domain 
swapped mutants at 85°C. The slopes are drawn by linear regression, 
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Figure 3.20 Relative thermostability of PYR::tp CS to PfCS at 95°C. 
The lines are drawn by linear regression.
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3.8 Discussion
3.8.1 Use of pAlter-1 kit in site directed mutagenesis
Many problems were encountered when using the pAlter-1 kit for site 
directed mutagenesis to create Apa1 and BspE1 sites in PfCS and TpCS, 
respectively. Firstly, it was found to be very difficult to recognise pAlter-1 
transformants because often white colonies tended to be pAlter-1 vector only 
clones. This meant that a very large number of clones had to be screened 
before pAlter-1 clones containing a citrate synthase gene were identified. 
Secondly, it proved very difficult to make the E.coli repair-minus cells supplied 
with the kit (strain ES1301) competent, which meant that another repair-minus 
strain, DH5a, had to be used. Finally, because of the high G:C content of the 
DNA coding for the CS’s, no mutants could be made starting with double 
stranded DNA.
The difficulties encountered making mutants using the pAlter-1 kit 
contrasted with the ease with which the Nde1-Kpn1 PYR::tp, and TP::pyr CS 
mutants were made using a PCR approach. For this reason in future a PCR 
mutagenesis method would be used in preference to the p-Alter method.
3.8.2. Kinetic studies of the mutants
It was fortunate that both domain swapped mutants within the pREC7- 
Nde1 vector (pBAP3008 and pBAP3010) expressed high levels of soluble 
proteins. It can be seen from Table 3.2 (showing a comparison of the specific 
activity and Km values for the 4 CS’s) that both domain-swapped mutants were 
active. This, coupled with the fact that the affinities for both substrates have not 
been greatly altered in the mutants, indicates that the mutant enzymes are
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adopting a similar conformation to the wild types. However, the fact that the 
TP::pyr CS enzyme is substrate inhibited with Ac-CoA indicates that the folding 
of this enzyme differs subtly from that of the wildtype TpCS and PfCS. This 
substrate inhibition effect is a direct consequence of the changes caused by the 
incorporation of the PfCS small domain into the TpCS large domain. This Ac- 
CoA substrate inhibition effect is discussed further in chapter 6.
There appears to be a correlation between the Km value for OAA and the 
large domain partner in Pf CS and PYRr.tp CS, and in Tp CS and TPr.pyr CS. 
This may be because two of the three OAA binding residues are located within 
the large domain of PfCS  and Tp CS.
From the specific activity values shown in table 3.2 it can be seen that 
the specific activity of the chimaeric mutant is related to the small domain 
partner at 55°C. This is shown by the fact that PfCS and TP::pyr CS have a 
similar specific activity at 55°C, and the specific activity of the PYR::tp CS 
mutant is approximately half of that of the TpCS at 55°C but nearly twice that of 
PfCS. This finding is consistent with the idea that the small domain determines 
the catalytic activity of the CS enzyme. This conclusion is perhaps not so 
surprising, because when one looks at the positions of the catalytic residues that 
have been predicted to play a central role in the mechanism of action of PfCS 
and TpCS (from the crystal structure), two of the three are located within the 
small domain, while the third lies in the hinge region between the large and 
small domains (Russell et al., 1994, 1997). This conclusion supports the 
findings of Molgat et al. (1992) who swapped the domains between E.coli CS 
and A.anitratum CS, and concluded from these mutants that the small domains 
of the CS enzymes are involved in catalytic activity.
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3.8.3 Thermal inactivation of mutant citrate synthases
From Fig 3.19 it can be seen that in terms of thermal stability at 85°C, 
PfCS, and PYR::tp CS>7pCS>TP::pyr CS. There is no observable difference in 
the thermal stability of PfCS and PYR::tp CS at 85°C. However at 85°C TpCS 
and TP::pyr CS show significant rates of denaturation (TpCS is nearly six times 
more thermostable than TP::pyr CS at this temperature). Thus by incorporating 
the region coding for the small domain of PfCS into the region coding for the 
large domain of TpCS, the resulting chimaeric CS is much more unstable than 
either of the wildtype CS’s. One possible reason for this is that the PfCS small 
domain may lack residues which help stabilise the TpCS (or change their spatial 
position within the molecule) thus disrupting the packing of TpCS and creating 
strain within the CS molecule, or it might form unfavourable interactions with the 
TpCS large domain. Perhaps one should not be surprised that one of the 
chimaeric mutants is unstable as each small domain region is being coupled 
with a large domain, which shows only 39% sequence identity at the amino acid 
level, to its wild type large domain partner. Other groups have found the thermal 
stability of chimaeric enzymes greatly reduced. Lebbink et al., (1995) found that 
one of their domain swap glutamate dehydrogenase mutants was less stable 
than either of the wild types from which the mutants were constructed. This led 
them to conclude that the presence of a domain from a hyperthermostable 
enzyme may not significantly enhance the temperature at which an enzyme 
becomes susceptible towards thermal inactivation. While this is true in the case 
of the TP::pyr CS, in PYR::tp CS the presence of the large domain from the 
hyperthermophilic PfCS significantly enhances the thermostability of the TpCS 
small domain with respect to TpCS.
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The fact that PYR::tp CS shows greater thermostability than TpCS at 
85°C indicates that the PfCS large domain is stabilising the TpCS small domain. 
This shows that the large domain of PfCS has a greater thermostabilising effect 
than the TpCS large domain. From this one could draw a conclusion that the 
structural features which make PfCS more thermostable than TpCS reside in the 
large domain, and that the major determinants of thermostability lie within the 
large domain. It is difficult to quantify how much more thermostable PYR::tp is 
compared with TpCS, because at 95°C when PYR::tp CS is showing a 
significant rate of denaturation, the activity of TpCS is destroyed in under 1 
minute. Similarly it is difficult to quantify just how much more thermostable PfCS 
is than PYR::tp CS, since at 95°C PfCS does not show a significant rate of 
denaturation (Fig 3.20), while at 103°C when PfCS shows a significant rate of 
denaturation (see Fig 5.16) all PYR::tp CS activity is destroyed in under 1 
minute. These results confirm the findings of Molgat et al., (1992), that it is the 
large domain region which plays the main stabilising role.
While these data point to the importance of the small domains to the 
catalytic activity of the CS’s under investigation, and the importance of the large 
domains to thermostability, it is more difficult to draw a conclusion about the 
importance of the small domains to thermostability, since in both cases changing 
the nature of the small domain reduces the thermostability properties of the 
large domain partner.
3.8.4 Concluding Comments
We have created soluble, active chimaeric enzymes which can be used 
to investigate the contributions of the large and small domains to thermostability. 
Given the structural homology between the psychrophilic DS23r CS and PfCS it
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would have been interesting to have made chimaeras with these two enzymes. 
However the structure of DS23r came too late in my project too do this. It was 
therefore decided to investigate the conclusion that the structural determinants 
of hyperthermostability in CS lie within the large domain, by making more citrate 
synthase mutants that would possess disrupted structural elements within the 
large domain of PfCS, which were predicted to play a role in thermostability from 
the crystal structure of PfCS.
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CHAPTER 4
Production of PfCS C-Terminal Mutants
4.1 Introduction
This chapter describes the creation and characterisation of two C- 
terminal mutants of PfCS, a -2 C-terminal amino acid deletion mutant (Pf-2), and 
a -13 C-terminal amino acid deletion mutant (Pf-13).
The C-terminal region of PfCS is located within the large domain. It was 
decided to investigate the importance of the C-terminal region of PfCS to 
thermostability because the crystal structure of the closed form of PfCS (Russell 
et al., 1997) has revealed that the C-terminal arm of one monomer appears to 
be wrapped around the N-terminus of the other monomer in an ‘intimate 
embrace’. It was predicted that this interaction might be playing a
thermostabilising role by forming a subunit interaction between the two 
monomers at the C-terminus of the protein. This C-terminal interaction has 
been observed in the closed form of PfCS but is not observed in low resolution 
studies of the open form of PfCS (R. J.M. Russell, personal communication) nor 
in the open form of TpCS. This has led to the idea that the C-terminal arm only 
becomes ordered upon the binding of the substrates oxaloacetate and Ac-CoA. 
Fig 4.1 shows the structure of the closed form of PfCS with each monomer 
shaded differently; the C-terminal arm of one monomer can be seen to be 





Figure 4.1 Space filling representation of the PfCS dimer, showing the 
C-terminal residues of each monomer wrapping around the other 
monomer.
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One can see by looking at an amino acid alignment of the C-terminal 
region of citrate synthases, from a number of organisms, that this region varies 
between different organisms (Fig 4.2). From Fig 4.2 it can be seen that the CS 
from the psychrophilic organism DS23r, B.subtilis R, and from pig are shorter at 
the C-terminus than PfCS, and are relatively thermolabile compared with PfCS, 
DS23r and pig CS being rapidly denatured at temperatures of 45°C and 60°C 
respectively.. One might suppose that the truncation of the C-terminal region 
relative to PfCS may be one reason for the relative thermolability of the CS’s 
from DS23r, B.subtilis, and pig, compared with PfCS. However it is very difficult 
to draw conclusions from amino acid alignments alone, because although pig 
CS and PfCS are slightly different in length at the C-terminus, the C-terminal 
region of PfCS is in an extended conformation with respect to pig CS. On the 
other hand DS23r CS with a 6 residue C-terminal deletion (relative to PfCS), 
forms a similar C-terminal interaction to PfCS, although the loss of the 6 
residues reduces the extent of the subunit interface (Russell et al., 1998). From 
Fig 4.2 it can also be seen that only the thermophilic CS’s have two positively 
charged amino acid residues at the C-terminus. Glutamate residue 48 to which 
Arg375 forms an ionic interaction in PfCS is conserved in the other CS’s shown.
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Number of end residue
DS23R RPLSEYNGPEQRQVP 379
E. coli R P R Q L Y IG Y E K R D F K S D IK 426
P ig R P K S M S TD G LIK LV D S K 437
Bacillus subtilis R R P S A Q Y TG A IP E E V LS 3 6 5
Thermoplasma R PR AVYVG PAER KYVPIA ER R K 384
Sulfolobus R PR ALYVG PEYQ EYVS ID KR 3 7 7
Pyrococcus R P R L Q Y V G E IG K K Y LP IE L R R 3 7 6
Figure 4.2 Amino acid alignment of CS C-terminal regions from Archaea, 
a Eukaryote, Gram negative and Gram positive bacteria.
To investigate the importance of the C-terminal region to the 
thermostability of PfCS it was decided to produce mutants of the enzyme where 
the C-terminal arm was deleted. The first C-terminal mutant constructed 
involved the removal of the 2 terminal arginine residues. This was to determine 
the importance of the ionic bond between the penultimate arginine residue 375 
and glutamate residue (48). This ionic bond is thought to anchor the whole C- 
terminal arm.
The second C-terminal mutant to be constructed involved removing the 
C-terminal arm from where it emerges from the inside of the PfCS molecule. 
This is thought to be after valine 362 residue which aligns with valine 370 from 
TpCS which is the last residue to be clearly defined from the open structure of 
TpCS. Rather than put stop codons after the valine 362 residue it was decided 
to put the stop codons after glycine 363 as one did not want to disrupt the 
QYVG hydrophobic sequence. The amino acid residues removed by this 
mutation are shown in Fig4.2 in italic.
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Several groups have investigated the importance of the C-terminal 
regions to thermal stability. Chen et al. (1995) investigated the importance of 
the C-terminal region of glucoamylase in terms of its thermostability and ability 
to bind starch by the deletion of 8 and 25 C-terminal residues. They found that 
the thermostability of the enzyme was unaffected but the enzyme progressively 
lost the ability to bind and hydrolyse starch. Meinnel et al. (1996) progressively 
deleted the C-terminal residues of E.coli peptide deformylase and found that the 
last 21 amino acid residues may be omitted without loss of activity, and that the 
truncated form was in fact more thermostable than the wild type.
4.2 Creation of the Pf-2 C-terminal deleted PfCS mutant
A decision was made to use PCR to create this mutant. The 5’ sense 
primer used was MAA-7, which bound to and amplified from the 5’ end of the 
PfCS gene (see section 3.5.1) adding an Nde1 site. The antisense primer used 
was MAA-15 (see Fig 4.3) which added a stop codon after the DNA sequence 
coding for the third amino acid residue (residue 374) from the end of the C- 
terminal arm, and contained a Kpn1 site to allow cloning of the CS into the 
pRec7-Nde1 vector.
S’TTTTTI' GG TA CCCTATA ATT CTATGGGTAG 3’
Figure 4.3 MAA-15 Primer. The bases shown in bold represent the stop 
codon, the bases shown in italics represent the Kpn1 site, the underlined 
bases code for the amino acids preceding the 2 penultimate amino acid 
residues.
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0.5pg template DNA [pBAP3031(P/CS in pRec7Nde1)], 5mM MgCI2, and 
18 pmoles of each primer were used in each reaction; for the other PCR 
conditions see section 2.2.11. Several identical PCR reactions were set up in 
order to obtain large quantities of the PCR product. Samples of two of the PCR 
reactions were run on a 1% agarose minigel, along with pRec7-Nde1 digested 
singly with Nde1 and Kpn1 (Fig 4.4). From this gel it can be seen that the PCR 
product corresponded to 1.3 kb in size.
1 2 3 4 5
 <---------  2.5kb
 <---------  1.3kb
Figure 4.4 PCR products and Nde1 and Kpn1 single digests of 
pRec7-Nde1 vector. 1) kilobase ladder DNA. 2) -2 PCR product.
3)-2 PCR product. 4) pRec7-Nde1 digested with Nde1 enzyme. 5) 
pRec7-Nde1 digested with Kpn1 enzyme.
The PCR product was purified using the Gene Clean method before 
being double digested with Nde1, and Kpn1. The Nde1-Kpn1 digested PCR 
product was again purified using the Gene Clean method and an overnight 
ligation was set up at 15°C between digested vector and insert (see sections 
2.2.7, and 2.2.8). The following day the ligation reactions were transformed into 
the CS-minus E.coli strain MOB154 and plated out onto LA plates containing 
ampicillin at a concentration of 125pg/ml. No transformants appeared on the
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vector only control so several colonies were picked from the vector +insert 
plates and were restreaked and ‘miniprep’ DNA prepared from them. This DNA 
was digested with Nde1 and the digests run on a 1% agarose gel; bands of 3.8 
Kb could be seen (gel not shown) which corresponded to the PfCS gene in the 
pRec7-Nde1 vector. A recombinant was sequenced using primer MAA-10 
[which binds downstream from the Kpn1 site of pRec7-Nde1 (see Appendix A) 
allowing the antisense strand of any gene cloned into the pRec7-Nde1 vector to 
be read]. Sequencing with the MAA-10 primer identified a Pf-2 mutant. This 2 
C-terminally deleted PfCS clone within the vector pRec7-Nde1 was designated 
pBAP3011. This clone was sequenced completely using primers MAA-9 and 
MAA-11 (see Appendix A) to determine whether any extra mutations had been 
introduced by the PCR procedure. No further mutations were found.
4.3 Creation of the Pf-13 C-terminal deleted PfCS mutant.
A similar strategy was used to produce the Pf-13 mutant as was used to 
create the Pf-2 mutant, the only difference being that a different C-terminal 
antisense primer, MAA-16, was used. This primer incorporated two stop codons 
upstream of the bases coding for the terminal 13 amino acids of PfCS (Fig 4.5).
5’ T^TTTGGTACCCTACTATCCTACATACTGCAACCTGGG3,
Figure 4.5 MAA-16 Primer. The Kpn1 site is shown in italics, the two 
stop codons are shown in bold, and the underlined bases code for the 
amino acids upstream of the 13 C-terminal amino acids.
0.5fig template DNA [pBAP3031(P/CS in pRec7Nde1)], 5mM MgCfe, and 
18 pmoles of each primer were used in each reaction; for the other PCR 
conditions see section 2.2.11. The PCR products were purified using the Gene
1 0 0
Clean method before being double digested with Nde1 and Kpn1. The Nde1- 
Kpn1 digested PCR product was again purified using the Gene Clean method 
and an overnight ligation was set up at 15°C between digested vector and 
insert. The following day the ligation reactions were transformed into the CS- 
minus E.coli strain MOB154 and plated out onto l_A plates containing ampicillin 
at a concentration of 125ng/ml (see sections 2.2.6, and 2.2.7). No colonies 
were obtained on the vector only control plates so several colonies were picked 
from the vector + insert plates and ‘miniprep’ DNA was prepared from these, 
which was then digested with Nde1 enzyme. A 1% (w/v) agarose minigel was 
run of these digests (Fig 4.6). From this gel it can be seen that most of the 
recombinants gave a 3.8 Kb band with Nde1 enzyme, showing that the -13 
PfCS PCR product had been cloned into pRec7-Nde1. One of these clones was 
sequenced initially with primer MAA-10 [which binds downstream from the Kpn1 
site of pRec7-Nde1 (see Appendix A) allowing the antisense strand of any gene 
cloned into the pRec7-Nde1 vector to be read]. The 13 C-terminally deleted 
PfCS clone identified by this sequencing was designated pBAP3013. The 
pBAP3013 construct was sequenced completely using primers MAA-9 and 
MAA-11 (see appendix A) to determine whether any extra mutations had been 
introduced by the PCR procedure. No further mutations were found.
1 0 1
1 2 3 4 5 6 7 8 9
<------3.8kb
Figure 4.6 Nde1 digest of vector + insert recombinants from the cloning 
of the -13 PfCS PCR product into pRec7-Nde1 vector. 1) kilobase ladder 
DNA. 2) Uncut miniprep 1 DNA. 3-9) Nde1 digested miniprep DNA 
samples.
Now that both C-terminal mutants had been confirmed by sequencing, 
the next step was to over express them and obtain pure protein for the purpose 
of characterisation.
4.5 Purification of the two PfCS C-terminal mutants
Cells were grown, induced, and cell extracts prepared (see sections 
2.3.2, and 2.3.3). Experiments were done to determine a suitable heat step for 
removing most of the E.coli host proteins from the cell extract without 
inactivating the mutant CS’s. A heat step of 80°C for 15 min was found to be 
adequate. Hence the 2 mutants were purified in the same way as the wild type 
PfCS. Table 4.1 shows the yields and specific activities obtained from each 
step of the purification, starting with 0.2g of cells. Fig 4.7 shows SDS-PAGE 
gels of samples taken during the purification of the Pf-2 and Pf-13 mutants. All 
the specific activity figures for the Pf-13 mutant are low because these assays
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were carried out using standard oxaloacetate and Ac-CoA concentrations (see 
section 2.3.6) which turned out to be approximately equal to the Km values for 
this enzyme, rather than 10 x Km as for PfCS and the Pf-2 mutant. All the 



























1 11.8 11.8 9.35 9.35 100 1.3*
Heat Step 0.9 11 9.9 7.75 7 84 1.4*




1 1.8 1.8 5.4 5.4 100 0.3
Heat step 0.7 2.3 1.6 2.5 1.85 87 0.8
Red gel A 3.6 0.25 0.9 0.16 0.39 50 2.3
Table 4.1 Purification of Pf-2 and Pf-13 PfCS mutants. All assays 
were carried out at 55°C. * Indicates that the specific activity 
values are low because of substrate inhibition by Ac-CoA.
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Figure 4.7 SDS-PAGE analysis of fractions from the purification 
of the Pf-2 and the Pf-13 mutants. 1)Low range molecular weight 
markers. 2) Cell extract. 3) Heat step. 4) Red gel A Unbound 
fraction. 5-6) Red gel A eluted fractions.
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4.6 Characterisation of the C-terminally deleted mutants.
4.6.1 Determination of the kinetic perameters
The Km and Vmax values for both C-terminal mutants were determined in
the same way as the domain swapped mutants (see section 3.7.1.). All 
measurements were repeated three times at 55°C, and the mean Km and 
specific activity values are shown in Table 4.2. The Km and Vmax values for wild 
type PfCS were determined at the same time for comparative purposes. The 
direct linear plot of Eisenthal and Cornish-Bowden (1974) was used to 
determine the Km and Vmax values, except in the case of the Pf-2 mutant which 
showed substrate inhibition by Ac-CoA. Here the Km and Vmax values were 
determined by using the Scientist plot to fit the rates to a curve given by the 
equation
  Vmax______
1+Km + _ S _
S Ki






P.furiosus 10 ±1.3 3.0 ±0 .7 17 ±2
Pf-2 16 ±1 5.0 ±0.8 * 35 ± 3
Pf-13 125 ±16 96 ± 8 8 ±1
Table 4.2 Km and Vmax values for PfCS and the C-terminally deleted 
PfCS mutants, indicates enzyme substrate inhibited by Ac-CoA. The 
mean Kj value for Ac-CoA for the Pf-2 mutant was 100 (± 4) |nM.
106
The V against S plots of the data used to determine the Km and Vmax 
values for the Pf-2 and Pf-13 CS mutants are shown in Fig 4.8a-d. These 
graphs were plotted in the same way as those in section 3.7.1 using the 
Microcal Origin graphics package. Note the Km value of the Pf-2 mutant for 
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Data: Pf-2 OAA 
Model: Michaelis-Menten 
Vm 0.0053 (± 0.0001) pmol/min
Km 15.6 (± 1.1) pM
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Figure 4.8a V against S plot of data used to determine the Km and Vmax 
values for the Pf-2 mutant for the substrate oxaloacetate.
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Figure 4.8b V against S plot for the substrate acetyl-CoA of data used to 
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Data: Pf-13 OAA  
Model: Michaelis-Menten 
Vm 0.00294 (± 0.00007) pmol/min





8 0 0 10000 200 400 600
[oxaloacetate] (^M)
Figure 4.8c V against S plot of data used to determine the Km and Vmax 




« ^  0.002 - Data: Pf-13 Ac-CoA  
Model: Michaelis-Menten 
Vm 0.0048 (± 0.00008) ymol/min
Km 94.0 (± 4.1) |jM
0.001 -
0 .000 -l h 
0 100 200 300 400 500
[Acetyl CoA] (p.M)
Figure 4.8d V against S plot of data used to calculate the Km and Vmax 
values of the Pf-13 mutant for the substrate Ac-CoA.
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4.6.2 Thermal stability of the C-terminally deleted mutated CS’s
The aim of these experiments was to compare the C-terminally deleted 
mutant CS enzymes with PfCS in terms of their abilities to withstand thermal 
inactivation.
All thermal stability studies were carried out at 103°C in the presence of 
50mM phosphate buffer, pH 7.2, containing 2mM EDTA, using an enzyme 
concentration of 0.1 mg/ml. The buffer was heated to the required temperature 
in an Eppendorf tube in a bath containing polyethylene glycol grade 400 (PEG 
bath), and the temperature was measured using an electronic temperature 
probe inside a second Eppendorf tube containing PEG grade 400 solution. 
When the desired buffer temperature was reached, enzyme was added to the 
Eppendorf tube, mixed with the buffer and the timer started. Aliquots were 
removed at timed intervals and placed into thin walled glass tubes on ice, where 
they were stored prior to assay. A time zero value was obtained by assaying a 
0.1 mg/ml concentration of enzyme in the same buffer kept at 4°C. Samples 
were assayed in triplicate, and the results are presented as a plot of In ( mean % 
activity remaining) against time. Fig 4.9 shows the relative thermal stability of 
the 2 C-terminally deleted mutants and PfCS at 103°C. From this graph it can 
be seen that in terms of thermostability PfCS >Pf-13 mutant >Pf-2 mutant. The 
rate constants for denaturation, and the times required to inactivate 50% of the 




Rate constant for 
inactivation (min'1)
Time required to 
inactivate 50% of 
enzyme (min)
PfCS 0.10 ±0.006 8.5
Pf-13 0.17 ±0.01 4.7
Pf-2 0.25 ± 0.02 2.6
Table 4.3 Rate constants for inactivation of PfCS, and the C-terminal 
mutants, and times at which 50% of the enzyme’s activity remains, at 
103°C.
From the rate constants for inactivation at 103°C, the change in the free 
energy of activation of thermal unfolding for both mutants compared to the 
wildtype PfCS was determined (using the method given in section 2.4). It was 
found that there was a decrease in the free energy of activation for thermal 
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4.7.1 Kinetic Studies of the mutants
It can be seen from Table 4.2 (showing a comparison of the specific 
activity and Km values for the 2 mutants and PfCS) that both C-terminal PfCS 
mutants were active. In the case of the Pf-2 mutant, where the Km values for 
the substrates oxaloacetate and Ac-CoA were relatively unchanged relative to 
PfCS, the enzyme can be assumed to be folding in a similar way to PfCS. 
However there must be a subtle difference in the enzyme’s folding, as this 
enzyme is substrate inhibited with Ac-CoA, a phenomenon also observed with 
the TP::pyr CS (see section 3.8.2). This substrate inhibition is a consequence of 
removing the 2 terminal arginine residues. One could argue that this is 
occurring either as a result of the destruction of the ionic interaction between 
Glu 48 and Arg 375, or because of the physical shortening of this C-terminal 
arm. One way to investigate whether or not the destruction of the ionic 
interaction was the cause of this effect would be to mutate Glu 48 or Arg 375 to 
an amino acid with an uncharged side chain such as serine thus destroying the 
ionic interaction but leaving the C-terminus of the protein unchanged in terms of 
its length.
The fact that the Pf-2 mutant has a specific activity at 55°C of double 
that of PfCS indicates that this mutant is more efficient at producing citrate than 
the wildtype PfCS. Again this could be a consequence of the destruction of the 
Arg 375-Glu 48 ionic bond, or as a result of the enzyme being shortened by 2 
amino acid residues. Perhaps the destruction of the Arg 375-Glu 48 bond 
changes the dynamic properties of the enzyme so that the enzyme becomes
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less rigid and more flexible, enabling it to convert substrate into product more 
rapidly at 55°C.
In the case of the Pf-13 mutant, the Km values are changed significantly 
as a result of the deletion, which may indicate that the enzyme is adopting a 
subtly different folded conformation at the C-terminal subunit interface 
(compared to PfCS) which affects the binding of the substrates and the specific 
activity of the mutant. It is interesting that the Pf-13 mutant is not substrate 
inhibited by Ac-CoA, in contrast to the Pf-2 mutant. Perhaps once the 2 terminal 
amino acids are removed from PfCS, the remainder of the C-terminal arm 
contributes to the Ac-CoA substrate inhibition conformation, so that when this 
region is removed the PfCS is no longer Ac-CoA inhibited.
4.7.2 Thermal inactivation of the C-terminal mutants
From Fig 4.9 it can be seen that in terms of thermostability PfCS> Pf-13 
>Pf-2 mutant. The Pf-2 mutant had a half life at 103°C of almost half that of the 
Pf-13 mutant, and a third of the half life of PfCS. This indicates that the 
resistance towards thermal unfolding is strongly diminished both by the removal 
of the 2 C-terminal and 13 C-terminal amino acid residues. This suggests that 
both the ionic interaction between Glu 48 and Arg 375, and the C-terminal arm 
as a whole, play a thermostabilising role in PfCS. The decrease in free energy 
of activation of thermal inactivation calculated for both mutants is similar to that 
calculated by Pappenberger et al. (1997). They found that the free energy of 
activation of thermal unfolding of glyceraldehyde-3-phosphate dehydrogenase 
was decreased by 4kJ/mol when the central residue of an ionic network was 
replaced by an uncharged alanine residue.
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One question that these results raise is why the more C-terminally 
deleted Pf-13 CS should be more thermostable than the Pf-2 CS, because the 
Pf-13 mutant will also have had its Glu 48-Arg 375 ionic interaction destroyed. 
Meinnel et al. (1996) have reported similar findings from their work on C-terminal 
mutants constructed from peptide deformylase. They found that when the 21 
and 23 terminal amino acids were removed from the peptide deformylase, the 
truncated mutant was more stable than the wildtype enzyme. Their explanation 
for the fact that the truncated form of the enzyme was more stable than the 
wildtype, was that in the wildtype enzyme the terminal 3 amino acids are 
disordered in the structure thereby causing relative instability to the catalytic 
core. Thus, when they are removed the enzyme is more stable. Therefore one 
explanation for the Pf-2 mutant being less thermostable than the Pf-13 mutant is 
that on loss of the ionic interaction at the C-terminus in the Pf-2 mutant the C- 
terminal arm becomes destabilising, and this destabilising effect is reduced 
when the extra 11 amino acid residues are removed in the Pf-13 mutant.
Hamana & Shinozawa (1999) also observed a decrease in 
thermostability in the C-terminal mutants that they constructed of orotate 
phosphoribosyl transferase (OPRTase) from Thermus thermophilus. In these 
mutants the terminal 1, 2, 3, and 5 amino acid residues were removed; all the 
mutants showed a significant decrease in thermostability compared to the 
wildtype enzyme, which led them to suggest that the terminal five amino acids at 
the C-terminus contribute to the stabilisation of the enzyme. All the mutants 
showed lower specific activities compared with the wildtype, and the Km value 
for one substrate was found to have increased 4 fold in all the mutants while the 
Km value for the other substrate was unchanged compared to the wild type 
enzyme. These results suggested that three of the deleted C-terminal residues
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were important for orotate binding to OPRTase and the deletion of a few amino 
acids from the C-terminus caused structural changes to the active site. These 
results are similar to our findings in that removal of C-terminal residues from 
PfCS caused changes to the enzyme’s thermostability and catalytic activity.
4.7.3 Concluding Comments
These results show that the whole C-terminal arm, from where it leaves 
the core of the PfCS molecule, is dispensable for activity, in that the enzyme still 
retains activity without it. However they show that the whole C-terminal arm, 
and in particular the 2 terminal amino acid residues (and the ionic interaction 
between Glu 48 and Arg 375), play a role in the thermostability of PfCS, as 
predicted from crystal structural comparisons.
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CHAPTERS
Production of PfCS subunit interface ionic network mutants
5.1 Introduction
In PfCS the monomer-monomer association is made up of two parts: the 
interaction of the C-terminus of one monomer with the N-terminus of the other 
monomer (as described in chapter4), and interactions centred on an eight a- 
helical sandwich, comprising four antiparallel pairs of helices (F, G, L, and M). 
For the purposes of this chapter the term subunit interface refers to the 
interactions between the 8 a-helical sandwich and not the C and N terminal 
interactions.
In comparison with CS’s isolated from organisms that live at lower 
temperatures than P.furiosus, PfCS has the greatest number of intersubunit 
ionic interactions. In addition there are a greater number of ionic interactions 
within the 8 a-helical sandwich region at the subunit interface of PfCS than 
found in any other CS. PfCS possesses two five-membered ionic networks in 
this region (Russell et al., 1997). The five-membered ionic PfCS ionic network is 
shown in Fig 5.1. Fig 5.2 shows a diagrammatic representation of the ionic ring 
network present in PfCS at each end of the subunit interface region. Fig 5.3 
shows the ionic interactions present at the 8 a-helical sandwich interface region 
of CS (calculated at a cut-off distance of 4A) for pig, DS23r, T.acidophilum, S 
solfataricus, and P.furiosus. It can be seen that pig CS has none, TpCS has a 
single interaction, S.solfataricus CS has two which are not networked, PfCS has
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Figure 5.1 Five membered intersubunit ion pair networks in PfCS, 
viewed down the two fold axis of the dimer. Equivalent helices (G -brown, 










Figure 5.2 Representation of the 5 membered ionic network at the 
subunit interface of PfCS, one monomer is shaded in purple while the 
other is shaded in light blue. The ionic network is not drawn to scale.
119
>'< v. i y \L ••-‘a- J I  %
' ■'«, Thermoplasrna ^ S . .v /  *
\  W % K . tl:d
Figure 5.3 Ion pairs present at the 8 a-helical sandwich subunit interface 
region of CS (calculated at a cut-off distance of 4A) for pig, DS23R, 
S.solfataricus, T.acidophilum, and P.furiosus. Helix G -brown. Helix M - 
green.
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5 which are networked, while DS23r CS has two intersubunit ionic interactions 
and two intrasubunit interactions at the subunit interface. The presence of these 
complex ion pair networks has been observed in the structure of other 
hyperthermophilic enzymes such as glutamate dehydrogenase, and they are 
thought to be essential for stability at high temperatures (Yip et al., 1995, 1998).
The extensive ionic network at the subunit interface of PfCS has been 
predicted to play a key role in the thermostability of the enzyme by maintaining 
the enzyme’s dimeric integrity at raised temperatures (Russell et al., 1997) and 
may be one of the reasons why PfCS is more thermostable than TpCS.
It was proposed to test the prediction of the importance of the 
intersubunit ionic network to thermostability in PfCS by using site directed 
mutagenesis to change residues involved in the network. Asp 113 was chosen 
as a target for mutagenesis as it is thought to participate in 60% of the ionic 
interactions at the PfCS subunit interface, and because there is no equivalent 
residue to Asp113 found in the amino acid sequence alignment between PfCS 
and TpCS. From Fig 5.1c it can be observed that Asp113 forms ionic bonds 
with Lys 219, His 93, and Arg 99. Thus, by substituting Asp113 with another 
residue, the ionic bonding present at the subunit interface of PfCS can be 
considerably disrupted.
This chapter describes the disruption of the ionic network at the subunit 
interface of PfCS by the substitution of Asp113 with an alanine and a serine 
residue. Alanine was chosen as a replacement for Asp113 because its side 
chain cannot form any ionic interactions. Serine was chosen as a replacement 
for Asp113 because its side chain cannot form ionic interactions but it contains a
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hydroxyl group which is capable of forming hydrogen bonds. The 
characterisation of both mutants with respect to PfCS is then described.
Several other groups have investigated the importance of subunit 
interactions to protein thermostability. Pozo et al. (1996) investigated the 
importance of a Trp 139 in bacterial D-amino acid transferase. This residue is 
located in a hydrophobic pocket at the subunit interface region, and when 
substituted for alanine, proline or histidine, the thermostability of the enzyme 
was decreased significantly. It was concluded from this that interactions of the 
Trp-139 residue at the subunit interface are important for the catalytic activity 
and thermostability of the enzyme.
Erduran & Kocabiyik (1998) have investigated the role of hydrophobic 
interactions at the dimer interface of TpCS. They did this by amino acid 
substitutions in the interface helices of TpCS; Ala 97-Ser, Ala 104-Thr (these 
substituted amino acids are found at the equivalent position in the more 
hydrophilic pig CS subunit interface), Gly209-Ala (the alanine residue being 
found in the equivalent position at the subunit interface of PfCS). They found 
that amino acid substitutions increasing or decreasing interface hydrophobicity 
led to an increase in the thermostability of TpCS. They concluded from this that 
if one wants to increase the thermostability of an enzyme by engineering the 
subunit interface region, then one must take into account the packing effect of 
the residues as well as their degree of hydrophobicity.
Mandelman et al. (1998) made point mutations at the subunit interface of 
ascorbate peroxidase to change an intersubunit ion pair to determine the effects 
of a neutral and repulsive mutation on dimerization and stability. Gel filtration 
analysis indicated that the ratio of monomer to dimer increased as the
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interactions went from attractive to repulsive. The thermal stability of the 
mutants was also decreased with respect to the wildtype.
Scopes et al. (1998) made mutations to reduce charge repulsion at the 
subunit interface of human glucose-6-phosphate dehydrogenase, and found 
that these mutations increased the thermostability of the enzyme.
Vetriani et al. (1998) noticed from a comparison of the structures of 
glutamate dehydrogenases from Thermococcus litoralis, and P.furiosus, that an 
intersubunit ion pair network was substantially reduced in T.litoralis. When two 
residues were mutated to restore this ionic network, the thermostability of the 
T.litoralis glutamate dehydrogenase enzyme was substantially increased.
Pappenberger et al., (1997) have investigated the importance of a four 
membered ionic network (intra subunit) in glyceraldehyde-3-phosphate 
dehydrogenase from the hyperthermophilic bacterium Thermotoga maritima . 
They did this by replacing the central member of this ionic network (Arg 20 ) by 
replacing it with either alanine or asparagine. They found that resistance 
towards thermal denaturation was strongly diminished in the mutant enzymes. 
They concluded from this that the ionic network around the Arg 20 residue is 




The technique used to mutate the Asp113 residue was nested PCR. 
Nested PCR is a two step process. In the first step, PCR is carried out using a 
primer containing the mutation to be introduced. This produces a DNA fragment 
which is then purified and used as one of the primers in the second PCR 
reaction. Because the PCR 1 product is relatively large compared to a standard 
primer designed for PCR, the PCR conditions in the second PCR are different 
from the first to take account of problems associated with annealing of the larger 
primer. An outline view of the nested PCR process is shown in Fig 5.4.
Primer 1*
Template DNA prjmer 2
PCR product 1
PCR product 1 used as 
primer in second PCR.
Figure 5.4 Steps in the nested PCR procedure. ‘ Denotes the primer 
containing the mutation to be introduced -
Primer 3 
PCR 2 — = *
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5.3 Production of the Alanine and Serine PfCS subunit interface
mutants
5.3.1 Production of the first PCR product
The nested PCR technique was used to create the subunit interface 
mutants because there were no suitable restriction sites adjacent to the Asp 113 
position that would have allowed a standard PCR mutagenesis approach (as 
used in chapter 4) to be used. The primers used in the PCR 1 reactions are 
shown in Fig 5.5. MAA17 was the sense primer designed to change the Asp113 
amino acid residue to an alanine residue, and MAA18 was the sense primer 
designed to change the Asp113 residue to a serine residue. These primers bind 
to the DNA between positions 413 and 443 of the PfCS DNA sequence. The 
sequences shown in bold code for alanine and serine respectively. MAA19 is 
the antisense primer used in each of the PCR 1 reactions and binds to the Apa1 




Figure 5.5 Primers used to create the PCR 1 products. The sequences 
shown in bold code for alanine and serine respectively. The nucleotides 
shown in italics represent the Apa1 site of PfCS.
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The PCR thermocycler programme used to create the PCR 1 product 
was the same as that described in section 2.2.11. The reagents used in the 
PCR reactions are shown below.
12pmoles of each primer 
50pmol of each dNTP 
50 ng pBAP 3031 template DNA 
2 Units of Taq polymerase 
x10 Taq polymerase buffer 
5mM MgCI2
Products from the PCR 1 reactions were run on a 1% (w/v) agarose 
minigel and were purified by the Gene Clean method. A photograph of samples 
of the purified PCR1 products run on a 1% agarose minigel is shown in Fig 5.6. 
It can be seen from this gel that the PCR 1 products were about 350 bp in 
length which was the expected size of the fragments.
1 2 3
350bp
Figure 5.6 PCR 1 products. 1) Kilobase ladder DNA. 2) Serine mutant 
PCR 1 product. 3) Alanine mutant PCR 1 product.
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5.3.2 Production of the second PCR product
While the purpose of the first PCR reaction was to create mutant DNA 
fragments for use as primers in the second PCR, the purpose of the second 
PCR reaction was to add an Nde1 site to allow the fragments to be cloned into 
the pBAP3031 construct (PfCS in pRec7-Nde1).
The PCR 1 products produced and purified in section 5.3.1 were used as 
the antisense primers for the second PCR reaction, while primer MAA-7 (see 
section 3.5.1) was used as the sense primer. The PCR 2 conditions were as 
follows.
Thermocycler PCR programme and reagent concentrations used are those 
described by Landt et al., (1990). This was to take account of the difficulties 
involved in using a long primer in PCR.
Programme:
95°C For 1 min 
55°C For 5 min 
72°C For 2 min
72°C For 10 min after 30 cycles.
This was followed by a cooling step of 4°C until the samples were retrieved for 
analysis
Reagents: 50 ng pBAP3031 template DNA
12 pmoles MAA-7 primer 
0.2 i^g PCR 1 product 
2 units of Taq polymerase.
X10 Taq buffer 
200 pM of each dNTP 
6mM MgCI2
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Following the PCR, the PCR2 reactions were run on a 1% agarose 
minigel, (Fig 5.7). Gel bands of 700 bp could clearly be seen, which was the 
expected size of the PCR 2 products. The 700 bp bands were cut out of the gel 
and purified by the Gene Clean method.
1 2 3
<--------700 bp
Figure 5.7 Products of PCR 2 reaction. 1) Serine mutant PCR 2 
product. 2) Kilobase ladder DNA. 3) Alanine mutant PCR 2 product
5.3.3 Cloning of the PCR 2 products into pBAP3031
To clone the PCR 2 products into pBAP3031, they were double digested 
with Apa1 and Nde1; pBAP3031 DNA (pRec7-Nde1 vector containing the PfCS 
gene) was also digested at the same time. This acted as a control that the Apa1 
and Nde1 enzymes were actually cutting. The pBAP3031 Nde1-Apa1 digest 
was run out on a 1% agarose minigel and the 3.1 kb band was excised from the 
gel and purified using the Gene Clean procedure. The Apa1-Nde1 digest of the 
PCR 2 products was also run on a 1% agarose minigel and the 700bp bands 
excised from the gel and purified using the Gene Clean procedure. An 
overnight ligation was set up to ligate the band purified Nde1-Apa1 digested 
PCR 2 fragments into the band purified Apa1-Nde1 digested PfCS pRec7-Nde1 
construct. The following day these ligations were transformed into the CS-minus
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MOB154 E.coli strain, and were plated onto LA plates containing ampicillin at a 
concentration of 125|xg/ml. A number of colonies were chosen from the vector + 
insert plates and were grown up and ‘miniprep’ DNA prepared from them.
It was possible to identify whether the recombinants were pBAP3031 or 
contained the subunit interface mutated Nde1-Apa1 fragments by restriction 
digestion, because by changing the DNA coding for the Asp 113 residue to that 
coding for a serine and an alanine residue, a BamHland Hinfl site, were 
created respectively. There is only one BamH1 site in the pBAP3031 construct 
and thus a serine subunit interface mutant (Asp113/Ser) would give 2 bands 
when digested with BamH1. The pBAP3031 construct contains 5 Hinfl sites, so 
an alanine subunit interface mutant (Asp113/Ala) would give an altered band 
pattern when digested with Hinfl.
‘Miniprep’ DNA from recombinants (from the cloning of both subunit 
interface mutants into the Apa1-Nde1 digested PfCS pRec7-Nde1 construct) 
was digested with BamH1 and Hinfl and run on a gel (Fig 5.8). It can be seen 
from this gel that clone 6 gave two bands with BamH1, which identified it as an 
Asp113/Ser mutant (designated pBAP3040), and that clone 2 gave an altered 
band pattern when digested with Hinfl thus identifying it as an Asp113/Ala 
mutant (designated pBAP3041). Note the digests run in lanes 2 and 7 were for 
the purpose of checking DNA stocks of the pRec7-Nde1 vector and pBAP3031.
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Figure 5.8 Restriction digest of potential subunit interface mutants. 1) 
kilobase ladder DNA. 2) pRec7-Nde1 vector digested with Nde1. 3) 
PfCS in pRec7-Nde1 (pBAP3031) digested with H in fl 4) Clone 2, 
Asp113/Ala mutant digested with H in fl 5) PfCS in pRec7-Nde1 
(pBAP3031) digested with Bam Hl 6) Clone 6, Asp113/Ser mutant 
digested with Bam Hl 7) pBAP3031 Nde1-KpN1 digest 8) Uncut 
pBAP3031
5.3.4 Sequencing of subunit interface mutants pBAP3040 and 3041
Although the number of bands obtained from the BamHl and Hinfl 
digest were as predicted, the sizes of the bands were smaller than expected. 
For this reason it was decided to sequence completely the 1.3 kb CS inserts of 
the pBAP3040 and pBAP3041 clones. Primers MAA-9, and MAA-10 .were used 
to sequence in from either end of the insert and MAA-11 was used to sequence 
from base position 518 (on the sense strand of PfCS).
The pBAP3041 sequence was found to have a 119bp deletion from 
base 625 to base 744, and an insertion of one T base at position 626 (a deletion 
from the BstX1 site to the Apa1 site), and occurred after the intended 
Asp113/ala mutation (see Fig 5.9). The remainder of the sequence of the 1.3 
Kb insert was as expected. The insertion of the extra T base at position 626 
alters the reading frame of the CS which resulted in a truncation of the protein at
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amino acid residue 187. The reason why this deletion occurred is hard to 
explain, although there is a region adjacent to the BstX1 site which resembles 
an Apa1 site, and it is possible that the Apa1 enzyme cut at this position as well 





GCCATGGA l^ l GGGCC^AATCCATGGAGG Alanine subunit
mutant
750I





Figure 5.9 DNA base sequence of the subunit interface mutants 
spanning the deleted region. The PfCS sequence is shown at the top, 
the dashed lines represent bases between position 638 to 745, and the 
sequence adjacent to the BStX1 1 site which was cut by Apa1 is shown 
in bold. The natural Apa1 and BstX1 sites are underlined on the PfCS 
sequence.
pBAP3040 (Asp113/Ser mutant) was found to have a similar deletion to 
pBAP3041 in that there was a deletion from base number 632 to base 750. 
Again this deletion threw out the reading frame of this mutant resulting in 
truncation of the protein at amino acid residue 188. The sequence obtained at
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this region is shown in Fig 5.9; the sequence of the remainder of the 1.3 kb CS 
insert was as expected.
5.3.5 Remaking the two subunit interface mutants
The large deletions in both subunit interface mutants made it necessary 
to remake both subunit interface mutants. However, because it was not clear 
how the extra mutations arose in the subunit interface mutants, pBAP3040 and 
pBAP3041, it was thought best not to repeat the same cloning procedure, in 
case the same deletions occurred again. As the rest of the sequence of both of 
the subunit interface mutants was correct, it was decided to cut out a fragment 
containing the subunit interface mutation from pBAP3040 and pBAP3041 (but 
none of the extra mutations), and clone each fragment into pBAP3031 (PfCS in 






Figure 5.10 Restriction sites used to subclone the subunit interface 
mutants into PfCS in pRec7-Nde1 (pBAP3031). The coloured boxes 
represent the mutated Asp113 residue. The restriction sites used to 
subclone the subunit interface mutants are shown in bold.
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5.3.5.1 Remaking the serine subunit interface mutant
The strategy used to remake the Asp113/ser mutant was to cut out the 
region containing the Asp113/ser mutation on an Nde1-BstX1 fragment, and 
clone this into pBAP3031 (P/CS in pRec7-Nde1), which had the corresponding 
Nde1-BstX1 fragment previously removed. A large scale digest of pBAP3040 
and pBAP3031 was set up with the enzymes Nde1 and BstX1. The digests 
were run on a 1% agarose minigel and the 540 bp Asp113/ser mutant Nde1- 
BstX1 fragment, as well as the 3.3 kb P/CS Nde1-BstX1 fragment, were cut out 
of the gel and purified using the Gene Clean method (Fig 5.11).
3 kb 
540 bp
Figure 5.11 Restriction digest of pBAP3040, and pBAP3031 with Nde1 
and BstX1. 1) Kilobase ladder. 2) Uncut pBAP3031. 3) pBAP3031 
digested with BstX1. 4) pBAP3040 digested with BstX1. 5) pBAP3040 
digested with Nde1. 6) pBAP3031 digested with Nde1 and BstX1. 
7) pBAP3040 digested with Nde1 and BstX1.
An overnight ligation was set up at 15°C of the purified 540 bp Nde1- 
BstX1 subunit interface fragment and the purified 3.3 kb P/CS Nde1-BstX1 
fragment. The following day the ligations were transformed into the CS-minus
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E.coli strain MOB 154, colonies were picked and ‘miniprep’ DNA was prepared 
from them. The ‘miniprep’ DNA was digested with BamH1 (Fig 5.12). It can be 
seen that all the clones, except for number 3 (lane 4), contained the serine 
subunit interface mutation. The reason that there is such a variation in the 
banding pattern between clones in Fig 5.12 is that some of the ‘miniprep’ DNA 
samples have cut better than others.
2 3 4 5 67  8 9
3.0 kb
800 bp
Figure 5.12 BamH1 digest of potential serine subunit interface mutants. 
Key. 1) Kilobase ladder. 2-9) Clones 1-8 inclusive.
Clone 2 had its insert sequenced completely using the sequencing 
primers MAA-9, MAA-10, and MAA-21. The sequence showed that this clone 
contained the serine subunit interface mutation but did not contain any other 
mutations. The repaired Asp113/Ser mutant within the pRec7-Nde1 vector was 
designated pBAP3014.
5.3.5.2 Remaking the alanine subunit interface mutant
The strategy for remaking the Asp113/Ala mutant was to cut out the 
region containing the Asp113/ala mutant on an Nde1-Bsa1 fragment and clone 
this into pBAP3031 (P/CS in pRec7-Nde1), which had the corresponding Nde1-
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Bsa1 fragment previously removed. The BstX1 site could not be used for 
remaking this mutant as the BstX1 site was destroyed in pBAP3041by the 
119bp deletion and T base insertion (see section 5.3.4). The Bsa1 site was not 
chosen for repairing the serine subunit interface mutant as the pBAP3031 
construct has two Bsa1 sites (which complicates any cloning using a Bsa1 site).
A large scale digest of pBAP3041 and pBAP3031 was set up with the 
enzyme Bsa1. After 3 hours a sample was taken from this digest and run on a 
1% agarose minigel. This gave two bands of 2.0 kb and 1.8 kb in size (gel not 
shown); Nde1 restriction enzyme was added to the remainder of the Bsa1 digest 
and left for a further 3 hours. The doubly-digested DNA was run on a 1% 
agarose minigel (Fig 5.13), showing that three bands were produced from each 
clone. The 450 bp Nde1-Bsa1 fragment from pBAP3041, and the 1.3 kb and 
2.0 kb fragments were excised from the gel and purified using the Gene Clean 
method. An overnight ligation was set up of the three purified Nde1-Bsa1 
fragments at 15°C. The following day the ligations were transformed into the 
CS-minus E.coli strain MOB154; no colonies appeared on the vector only plates 
but several colonies appeared on the vector + insert plates, these were picked 
and ‘miniprep’ DNA was prepared from them. The ‘miniprep’ DNA was digested 
with Nde1 and run on a 1% agarose gel to check that the recombinants were 3.8 
kb in size (gel not shown). The ‘miniprep’ DNA of one recombinant was 
sequenced using primer MAA-11 to determine whether the 119 bp deletion had 
been repaired, and the rest of the insert was sequenced using the primers MAA- 
9 and MAA-10 to check if any other mutations were present. None were found. 
The ‘repaired’ alanine subunit interface mutant was designated pBAP3015.
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Figure 5.13 Restriction digestion of pBAP3041, and pBAP3031 with 
Nde1 and Bsa1. 1) Kilobase ladder. 2) pBAP3041 doubly-digested with 
Nde1, and Bsa1. 3) pBAP3031 doubly-digested with Nde1 and Bsa1. 4) 
100 bp marker.
Now that both the serine and alanine subunit interface mutants had been 
confirmed by sequencing, the next step was to over express them and obtain 
pure protein for the purpose of characterisation.
5.4 Production and purification of the 2 subunit interface PfCS 
mutants
50ml of LB containing ampicillin at a concentration of 125pg/ml was 
inoculated with a single colony of E.coli MOB154 (CS-minus strain) transformed 
with the plasmid pBAP3015; this was grown up overnight at 37°C in a shaking 
incubator. The following day this culture was used to inoculate 500ml of LB 
containing ampicillin at a concentration of 125pg/ml in a 1 litre flask; this was 
incubated overnight on a shaking incubator at 37°C (at 200rpm) and the
136
following day nalidixic acid was added to the culture to give a final concentration 
of 50|ng/ml. The cells were then incubated overnight at 37°C in the shaking 
incubator and were harvested the following morning. The same method was 
used to grow up cells of E.coli MOB154 transformed with pBAP3014. 0.2g of 
cells were used to purify the CS (see sections 2.3.2 and 2.3.3). Experiments 
were done to determine a suitable heat step for removing most of the E.coli host 
proteins without losing too much of the CS activity. A heat step of 80°C for 15 
min was found to be adequate. Hence the two subunit interface mutants were 
purified in the same way as the wild type P/CS. Table 5.1 shows the yields and 
specific activities obtained from each step of the purification, starting with 0.2g 
of cells. Fig 5.14 shows SDS-PAGE gels of samples taken during the 

























Cell extract 1.0 8.4 8.4 8.1 8.1 100 1*
Heat Step 0.8 6.2 5 0.9 0.7 59 7*
Red gel A 3.0 1.2 3.5 0.086 0.25 42 14*
Asp113/Ala 
mutant
Cell extract 1 7.6 7.6 7.85 7.85 100 1.0*
Heat step 0.75 4.3 3.2 0.8 0.6 43 5.6*
Red gel A 3.0 0.8 2.3 0.06 0.17 30 13.5*
Table 5.1 Purification of the Asp113/Ser and Asp113/AIa subunit 
interface mutants. All assays were carried out at 55°C. 
* indicates that the specific activity values are low because of substrate 
inhibition by Ac-CoA.
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Figure 5.14 SDS-PAGE analysis of fractions from the purification of the 
Asp113/Ser and Asp113/ala mutants. 1) Low range molecular weight 
markers. 2) Cell extract. 3) Heat step. 4) Red gel A unbound fraction. 
5-7) Red gel A eluted fractions.
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5.5 Characterisation of the subunit interface P/CS mutants.
5.5.1 Determination of the kinetic perameters
The Km and Vmax values for both subunit interface mutants were 
determined in the same way as the domain swap mutants (see section 3.7.1).
All measurements were repeated three times at 55°C; the mean, and standard 
errors for the Km and Vmax values are shown in Table 5.5.1.. The direct linear 
plot of Eisenthal and Cornish-Bowden (1974) was used to determine the Km and 
Vmax values for the substrate oxaloacetate. However, because both subunit 
interface mutants were substrate inhibited by Ac-CoA, the Km and Vmax values for 
the substrate Ac-CoA were determined by using the Scientist plot to fit the rates 




The specific activity values shown in table 5.2 are calculated from the 
means of the Vmax values calculated for the substrate Ac-CoA, since the Vmax 
values calculated for the substrate oxaloacetate by the direct linear plot do not 
give a true value of Vmax because of substrate inhibition by Ac-CoA. The Km and 
Vmax values for OAA for the Asp113/Ala, and Asp113/Ser mutants were 
determined at an Ac-CoA concentration of 24pM and 9pM respectively, as these 
were the concentrations of Ac-CoA which gave the greatest rates of activity at 













P.furiosus 10 ±1.3 3.0 ±0.7 17 ±2
Serine subunit 
mutant
11 ±1 3.5 ±0.8  * 76 ± 2 27 ± 2
Alanine 
subunit mutant
13 ±3 3.4 ±0.2 * 122 ±28 28 ± 2
Table 5.2 Km and specific activity values determined for P/CS, and the 
subunit interface mutants at 55°C. ‘ indicates enzyme substrate inhibited 
by Ac-CoA.
V against S plots of the data used to determine the Km and Vmax values 
for the serine and alanine subunit interface mutants are shown in Figs 5.15a-d. 
These graphs were plotted in the same way as those in section 3.7.1 using the 





Data: Asp113/alanine OAA 
Model: Michaelis-menten 
Km 12.0 (± 0.03) |JM
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[oxaloacetate] (pM)
Figure 5.15a V against S plot for the Asp113/Ala mutant for the 
substrate oxaloacetate.
Data: Asp113/alanine Ac-CoA 
Model: Substrate inhibition 
Km 3.1 (± 0.5) pM
Ki 94.0 (±11.0) pM










Figure 5.15b V against S plot of data used to determine the Km and Vmax 






Data: A sp113/ser OAA  
Model: M ichaelis-Menten  
Vm 0 .0035  (±0 .00005) pmol/min
Km 13.4 (±  0 .7 ) pM
^  0 .0 0 1 5 -
0 .0010 -
0.0005 -
0.0000 +  
0 10050 150 200
[oxaloacetate] (pM)
Figure 5.15c V against S plot for the Asp113/Ser mutant for the substrate 
oxaloacetate.
0.0035 -
A sp113/ser Ac-CoA  
Model: Substrate inhibition 
Km 2 .9  (±  0 .6 ) pM
Ki 7 9 .0  (±  11.0) pM
Vm 0 .0046  (± 0 .0003) pmol/min
0.0030 -
0.0025 -
s ^  0.0020 -
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[acetyl-CoA] (pM)
Figure 5.15d V against S plot of data used to determine the Km and Vmax 
values for the Asp113/Ser mutant for the substrate Ac-CoA.
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5.5.2 Thermal stability of the subunit interface CS’s
The aim of these experiments was to compare the subunit interface 
mutants with P/CS in terms of their abilities to withstand thermal denaturation
All thermal stability studies were carried out in the presence of 50mM 
phosphate, pH 7.2, 2mM EDTA using an enzyme concentration of 0.1 mg/ml. 
The buffer was heated to the required temperature in an Eppendorf tube in a 
bath containing polyethylene glycol grade 400 (PEG bath). The emperature was 
measured using an electronic temperature probe inside an Eppendorf tube 
containing PEG grade 400 solution, placed in the bath. When the desired buffer 
temperature was reached enzyme was added to the Eppendorf tube, mixed with 
the buffer and the timer started. Aliquots were removed at timed intervals and 
placed into thin walled glass tubes on ice, where they were stored prior to assay. 
A time zero value was obtained by assaying an 0.1 mg/ml concentration of 
enzyme in the same buffer at 4°C. Samples were assayed in triplicate and a 
mean In (% activity remaining) value was calculated at each time point for each 
sample. A graph was plotted of the ln% (activity remaining) versus time to show 
the relative thermal stability of the two subunit interface mutants and P/CS at 
103°C (Fig 5.16). From this graph it can be seen that in terms of thermostability 
P/CS >serine subunit interface mutant >alanine subunit interface mutant. The 
rate constants for inactivation, and the times at which 50% of the enzymes 
activity remain at 103°C for P/CS and the two subunit interface mutants are 




Rate constant for 
inactivation (min'1)
Time at which 50% 
of activity remains 
(min)
P/CS 0.057 ± 0.002 12
Asp 113/Ser 0.16 ±0.005 4.3
Asp113/Ala 0.23 ±0.012 2.6
Table 5.3 Rate constants for denaturation of the subunit interface 
mutants and P/CS, and times at which 50% of the enzymes activity 
remains at 103°C.
From the rate constants for denaturation at 103°C calculated for the 
wildtype P/CS and the subunit interface mutants, the change in the free energy 
of activation of thermal inactivation for both mutants compared to the wildtype 
P/CS was determined (using the method given in section 2.4). It was found that 
there was a decrease in the free energy of activation for thermal unfolding of 
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Figure 5.16 Relative thermostability of the subunit interface mutants to 
P/CS at 103°C. The lines are drawn by linear regression.
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5.6 Discussion
5.6.1 Kinetic Studies of the mutants
It can be seen from Table 5.2 that both the subunit interface mutants 
were active, and showed very similar K„, values to P/CS with the substrates 
oxaloacetate and Ac-CoA (with the exception being that both mutants were 
substrate inhibited by Ac-CoA). Thus both mutants can be assumed to be 
folding in a similar way to P/CS. However there must be a subtle difference in 
the folding as both mutants were substrate inhibited with Ac-CoA, a 
phenomenon also observed with the TP::pyr CS domain swapped mutant (see 
section 3.8.2), and the C-terminal Pf-2 mutant (see section 4.7.1). This 
substrate inhibition is an unexpected consequence of mutating the Asp113 
residue, and it is difficult to explain why the mutation of the Asp113 residue 
should cause substrate inhibition with Ac-CoA. Both mutants showed a greater 
specific activity than P/CS; this could be a consequence of the partial 
destruction of the ionic network at the subunit interface, giving rise to an enzyme 
which is more flexible than P/CS at 55°C.
5.6.2 Thermal inactivation of the subunit interface mutants
From Fig 5.3 (showing the relative thermostabilities of the two subunit 
interface mutant CS’s to P/CS at 103°C) it can be seen that in terms of 
thermostability P/CS >Asp113/Ser mutant >Asp113/Ala mutant. The 
Asp113/Ala mutant had a half life at 103°C of almost half that of the Asp113/Ser 
mutant, and a quarter of P/CS. This indicates that the resistance towards 
thermal unfolding is strongly diminished in both subunit interface mutants. This 
suggests that the aspartate 113 residue plays an important role in the 5
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membered ionic network, and the thermostability of P/CS (as predicted from the 
crystal structure by Russell et al. [1997]). The decrease in the free energy of 
activation of thermal inactivation values, calculated for both mutants show good 
agreement with that determined by Pappenberger et al.(1997). These authors 
found that when they substituted the central residue in a 4 membered ionic 
network with non charged residues (in glyceraldehyde-3-phosphate 
dehydrogenase), the free energy of activation of thermal inactivation was 
decreased by about 4 kJ/mol, as compared to 3 and 4.2 kJ/mol for the 
Asp113/Ser and Asp113/Ala mutants, respectively, in the current study. 
However, it must be noted that Pappenberger et al (1997) were investigating an 
intramolecular ionic ring network rather than an intermolecular ionic ring 
network.
If one accepts that there is a difference in the thermostabilities of the two 
mutants one explanation why the Asp113/Ser mutant is more thermostable than 
the Asp113/Ala mutant is that the hydroxyl group from the side chain of serine at 
position 113 may form a hydrogen bond with His 93 (as this is within hydrogen 
bonding distance from Ser 113), thus creating an extra 2 hydrogen bonds at the 
subunit interface compared with the Asp113/Ala mutant, whose side chain 
cannot form any hydrogen bonds.
Although these results strongly suggest that the Asp113 residue, and the 
5 membered ionic ring network at the subunit interface of P/CS, plays an 
important role in the thermostability of P/CS, they also support a model which 
proposes that the thermostability of P/CS is made up of a number of 
thermostabilising interactions, since when this residue is substituted destroying 
60% of the ionic interactions at the subunit interface the thermostability of the 
enzyme is reduced but not destroyed.
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To extend this work, further mutants could be made where the P/CS 
subunit interface ionic network could be disrupted in a different position, or in 
addition to the mutation of the Asp113 residue, Asp206 could be mutated to 
destroy all of the ionic interactions at the subunit interface. Another strategy to 
investigate the importance of this ionic network to thermostability would be to 
create an ionic network at the subunit interface of TpCS similar to that found in 
P/CS by site directed mutagenesis to see if this increases the thermostability of 
TpCS.
5.7.3 Concluding Comments
These results show that the subunit interface ionic network in P/CS 
makes a contribution to the enzyme’s thermostability at high temperatures as 
predicted from the crystal structure. The fact that the enzyme’s thermostability is 
not drastically changed when 60% of the interactions are destroyed suggests 
that it is not just the 5 membered ionic network at the subunit interface of P/CS 
that is responsible for making P/CS more thermostable than TpCS (which lacks 




A number of predictions have been made from a comparison of the 
crystal structures of P/CS, TpCS, and pig CS, as to what structural features 
could lead to the enhanced thermostability of the P/CS relative to TpCS, and 
pigCS (Russell et al., 1997). These include: an increased compactness of the 
enzyme, a more intimate association of the subunits, an increase in the number 
of ion pairs and a reduction in the number of thermolabile residues.
Mutagenesis has been used to test some of these predictions. As 
described in chapter 3, domain swap mutants between the small domain of 
P/CS and TpCS were generated in order to determine where the principle 
determinants of thermostability and catalytic activity lie in P/CS and TpCS. 
These mutants were confirmed by N-terminal and DNA sequencing, and showed 
that in P/CS and TpCS the small domains are largely responsible for the 
catalytic activity of the enzyme, and that the structural determinants of 
thermostability were principally located within the large domains. Note the 
subunit interface comprises interactions between the large domains.
As a result of these findings it was decided to investigate the large 
domain of P/CS further, to try to determine which structural features within the 
large domain contributed to the enhanced thermostability of the P/CS. To this 
end, structural features which were predicted to play a role in the thermostability 
of P/CS (and which lie within the large domain), namely the C-terminal arm and 
the 5-membered ionic network at the subunit interface of P/CS, were mutated.
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As described in chapter 4, truncation mutants were made of P/CS. 
These were designed to test the importance of the 2 C-terminal residues (one of 
which is involved in a ionic interaction) and the whole C terminal arm (from 
where it exits the core of the molecule) to thermostability. These mutants were 
made by a PCR-based mutagenesis method and were confirmed by DNA 
sequencing. Both the Pf-2 and the Pf-13 mutants were significantly less 
thermostable than the wildtype P/CS, which indicates the importance of the C- 
terminal region to thermostability within P/CS. The Pf-2 mutant showed a two­
fold increase in specific activity compared with P/CS, which was attributed to an 
increase in the flexibility of the enzyme at 55°C, while the Pf-13 mutant showed 
greatly increased Km values for the substrates oxaloacetate and Ac-CoA, and a 
two-fold decrease in the specific activity compared with P/CS. One suggestion 
to explain the change in specific activity and in Km values in the Pf-13 mutant, is 
that the removal of the whole external part of the C-terminal arm (which forms 
part of the subunit interaction) affects the subunit interaction between the 
monomers, causing a small conformational change, leading to an increase in 
the Km values for the two substrates and a decrease in specific activity.
As described in chapter 5, subunit interface mutants were made where 
the Asp113 residue, which is the central residue in the subunit interface 5- 
membered ionic network, was substituted with an alanine and a serine residue, 
destroying 60% of the ionic interactions at the subunit interface. Both mutants 
were less stable than the wildtype P/CS, indicating the importance of the ionic 
interactions at the subunit interface to thermostability in P/CS. Both mutants 
displayed a greater specific activity at 55°C compared to P/CS, and this was 
attributed to an increase in the mutant enzyme’s intrinsic flexibility as a result of 
the disruption of this ionic network.
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These results confirm the predictions made from the structural 
comparison of pig, Tp, and P/CS that the 5-membered subunit interface ionic 
network, and C-terminal interactions play a role in the thermostability of P/CS. 
The changes in thermostability observed in the C-terminal and subunit interface 
mutants (chapters 4 and 5) suggest a model of protein thermostability of P/CS 
being composed of a number of interactions rather than just a few, since the 
changes in thermostability resulting from these mutations are minor ones. 
These results also show for the first time that in P/CS the principal determinants 
of thermal stability lie within the large domain of P/CS, and the principal 
determinants of catalytic activity reside in the small domain. The relationship of 
these results to other mutagenesis/thermostability studies is discussed in the 
discussion sections of chapters 3, 4, and 5.
A number of problems were encountered in the course of this study. 
These include the speed and reliability of generating mutants, experimental 
difficulties in assessing thermostability at around 100°C, and unexpected 
changes in enzyme properties. Both the pAlter and nested PCR methods used 
for carrying out mutations had inherent problems. The pAlter method was very 
slow (see chapter 3) and the nested PCR method gave rise to unwanted extra 
mutations (see chapter 5).
It was difficult to assess enzyme thermostability at temperatures around 
100°C by following the denaturation of the mutant and wild type enzymes, 
because of the problem of replicating the same conditions of temperature when 
working on different days . This may explain why there is such a difference in 
the half life times of P/CS at 103°C, as described in chapters 4 and 5. 
Therefore, the inactivation rate constants determined for the subunit interface
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mutants and the C-terminal mutants should be considered separately. For this 
reason one cannot really comment on whether the C-terminal mutants are more 
thermolabile than the subunit interface mutants. One way to get around this 
problem would be to ensure that one was in a position to assay all of the 
mutants in triplicate on the same day, or one could try carrying out the 
denaturations at lower temperatures for much longer periods of time. 
Alternatively the results could be presented as an Arrhenius plot and in this way 
one would not have to replicate the temperatures from day to day. Other groups 
such as Pappenberger et al., (1997), have used CD spectroscopy to follow 
denaturation, but the problem with this approach is that it assumes that the 
enzyme is denatured when it unfolds whereas a local change in structure (as 
opposed to unfolding) may be responsible for the loss of enzyme activity.
The global nature of interactions within a protein have made it difficult to 
explain some of the observations made during this project. An example of this 
is the unexpected change in some of the mutants’ properties, i.e. the substrate 
inhibition effect with Ac-CoA that has been observed with the TP::pyr, Pf-2, and 
both of the subunit interface mutants. What is difficult to understand is why 
such differing structural changes should give rise to the same effect, and why in 
the case of the C-terminal mutants should the Pf-2 mutant, but not the Pf-13 
mutant, be inhibited by Ac-CoA . One explanation for the Ac-CoA substrate 
inhibition in the affected mutants is that in P/CS and TpCS, oxaloacetate binds 
first causing a conformational change in the enzyme enabling it to bind Ac-CoA. 
In the substrate inhibited mutants however the Ac-CoA may be binding before 
the oxaloacetate, preventing the binding of the oxaloacetate.
This structural comparison/mutagenesis strategy for investigating the 
structural determinants of thermostability is hampered in this case by the lack of
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a crystal structure of a CS from a mesophilic archaeon, and lack of a crystal 
structure of the closed form of TpCS. If there was a crystal structure of a 
mesophilic archaeon then one could be a little more certain that differences in 
structure that are observed in moving from a mesophile to a thermophile and 
hyperthermophile are not of a phylogenetic origin. Also the crystal structure of 
the closed form of TpCS may reveal that there is very little difference in the C- 
terminal interactions between P/CS and TpCS. Hence one suggestion for future 
work would be to obtain the crystal structure of the closed form of a mesophilic 
archaeon, and the closed form of TpCS.
Another suggestion for future work would be the generation of further 
mutants. As well as the additional mutants described in the discussion sections 
in chapters 4 and 5, one could try mutating other regions within P/CS. For 
example one could mutate the intersubunit ion pair located at the N-terminus 
Lys 8-Asp16’ P/CS, to see if this ionic interaction played a role in the enzyme’s 
thermostability. One could extend the domain swap study by swapping the 
small domain of the psychrophilic organism DS23r with that of P/CS to see what 
the thermostability of the resultant chimaeric enzymes would be, given the vastly 
different thermostabilities of the wildtype enzymes. This would also test the 
validity of our conclusions from the present domain swap work.
An alternative approach for investigating what makes P/CS more 
thermostable than its counterpart from T.acidophilum would be to use an 
evolutionary technique with TpCS within P.furiosus, accumulating stabilising 
mutations by recombination, and random mutagenesis, an approach used by 
Akanuma et al. (1998). The aim of using this approach would be to determine 
what mutations evolve naturally to increase the thermostability of the TpCS. To
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produce mutants using the in vivo evolutionary technique one would first have to 
generate a CS-minus strain of P.furiosus and then integrate the CS gene from 
T.acidophiium into its chromosome. The resulting Pf strain (containing the 
chromosomally incorporated foreign CS) would then be cultured in conditions of 
increasing temperature to select for mutants of the CS which had evolved to 
withstand the increased temperatures. Alternatively one could use directed 
evolution, a method that involves random mutagenesis, but does not require in 
vivo selection in an extremophilic host (Kuchner & Arnold, 1997). The CS from 
these mutants would then be sequenced, the protein purified, and characterised 
to determine if the mutations had changed the structure of TpCS in ways that 
were predicted from Xray crystallographic comparisons of these enzymes with 
P/CS.
There remains a considerable scope for research into the area of protein 
thermostability and much work is required to unravel the complexities of the 
strategies of stabilisation employed in proteins from hyperthermophiles. The 
research carried out as part of this project has located the principal determinants 
of thermostability to the large domain in CS in the Archaea studied. The 
creation of more mutants within the large domain may shed more light on the 




Primers used for mutagenesis and sequencing reactions.
MAA-1 5’ CGCCGGGAGTTCCCGGGCGACGTACCGCC 3’
Used to introduce an Apa1 site into TpCS.
MAA-2 5’ GTTGACTACTGGTCCGGATTAGTTTTCTAT 3’
Used to introduce a BspE1 site into P/CS.
MAA-3 5’ TGCATCTACCACGGCAGGCT 3’
Used for sequencing, binds to the sense strand of TpCS between positions 842 
and 862.
MAA-4 5’ AG GTATAT GAG AT CGCCACG 3’
Used for sequencing, binds to the sense strand of TpCS between positions 
1144 and 1164.
MAA-5 5’ ACGCATCGACTTTAGCAGTA 3’
Used for sequencing, binds to the sense strand of P/CS between positions 660 
and 680.
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MAA-6 5’ AGCT CTT CG AG ATAGCT G AA 3’
Used for sequencing, binds to the sense strand of P/CS between positions 945 
and 965.
MAA-7 5' GGGAATTCCATATGAATACGGAAAAATACCTTGCT 3’
Used to add an Nde1 site to PYR::tp CS and P/CS by PCR. Binds to the sense 
strand of P/CS between positions 74 and 109.
MAA-8 5’ CGGGGTACCAATGCTCATTTTATCTACCTCC 3’
Used to add a Kpn1 site to PYR::tp CS and P/CS by PCR. Binds to the 
antisense strand of PfCS between positions 1243 AND 1212.
MAA-9 5’ CTTCAACAGAACATATTGTT 3’
Used for sequencing, binds between positions 367 and 347 on the sense strand 
of pRec7Nde1 vector.
MAA-10 5’ TTGCATGCCTGCAGGTCGAC 3’
Used for sequencing, binds to the antisense strand of the pRec7-Nde1 vector, 
between positions 264 and 284.
MAA-11 5’ GCTAATTGGTATAGAATTAAG 3’
Used for sequencing, binds to the sense strand of P/CS, between positions 497 
and 518.
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MAA-12 5’ TGTAGAGGTGTACATATGCCAGAAACTG 3’
Used for adding an Nde1 site to TP::pyr CS. Binds to the sense strand of 
TP::pyr CS between positions 255 and 283.
MAA-13 5’ TGCAGCCCGGGGGTACCGGATCCGAAAACAC 3’
Used for adding a Kpn1 site to TP::pyr CS. Binds to the antisense strand of 
TP::pyr CS between positions 1520 and 1508.
MAA-14 5’ TGGGTAACGCCAGGGTTTTC 3’
Used for sequencing TP::pyr within the pUC19 vector. Binds to the sense 
strand of the pUC19 vector 30bp upstream of the EcoR1 site.
MAA-15 5’ TTTTTTGGTACCCTATAATTCTATGGGTAG 3’
Used for adding a stop codon in front of the DNA sequence coding for the 2 
terminal amino acids of PfCS. Binds to the anti sense strand of PfCS between 
positions 1210 and 1195.
MAA-16 5’ TTTTTTGGTACCCTACTATCCTACATACTGCAACCTGGG 3’
Used for adding two stop codons in front of the DNA sequence coding for the 
terminal 13 amino acids of PfCS. Binds to the antisense strand of PfCS 
between positions 1177 and 1157.
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MAA-17 5’ GACGATAGTGGAGCGATTCCAGTAACCCCTG 3’
Used to mutate the Asp113 residue to an alanine residue. Primer binds to the 
sense strand of PfCS, between positions 413 and 444.
MAA-18 5’ GACG ATAGT GG AT CCATT CCAGTAACCCCT G 3’
Used to mutate the Asp113 residue to a serine residue. Primer binds to the 
sense strand of PfCS, between positions 413 and 444.
MAA-19 5’ CCATGGATTGGGCCCTTTAAAGC 3’
Antisense primer used to make the PCR1 products (see section 5.3.1). Binds to 
the antisense strand of PfCS between positions 759 and 737.
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Appendix B
List of clones constructed and used during this project
pBAP 3004 TpCS within pAlter-1 vector
pBAP 3104 PfCS within pAlter-1 vector
pBAP 3005 TpCS within pAlter-1 vector mutated to introduce an Apa1 site.
pBAP 3105 PfCS within pAlter-1 vector mutated to introduce a BspE1 site.
pBAP 3006 TP::pyr CS within pAlter-1 vector.
pBAP 3106 PYR::tp CS within pAlter-1 vector.
pBAP3007 TP::pyr CS within pUC19.
pBAP3008 TP::pyr CS within pRec7-Nde1.
pBAP3110 PYR::tp CS within pRec7-Nde1.
pBAP3011 Pf-2 mutant within pRec7-Nde1.
pBAP3013 Pf-13 mutant within pRec7-Nde1.
pBAP3014 Asp113/ser mutant within pRec7-Nde1.
PBAP3015 Asp113/ala mutant within pAlter-1.




Asp113/ser mutant (containing additional mutations) within pRec7- 
Nde1.
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